Dementia in Alzheimer disease

F5_ALZHDEMENT

Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00* Hospital discharge: ICD-8 — 29010 Cause of death: ICD-10 — F00* Cause of death: ICD-8 — 29010 2 out of 7 registries used, show all original rules.	9163
4. Check minimum number of events None	9163
5. Include endpoints None	9163
6. Filter based on genotype QC (FinnGen only)	8916

Control definitions (FinnGen only)

Control exclude: F5_ORGANIC

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF3

NAME	F5_ALZHDEMENT
CONTROL_EXCLUDE	F5_ORGANIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F00
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	29010
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F00
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	29010
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dementia in Alzheimer disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	128670	81960	45831
Only index persons	110175	71387	38788
Unadjusted period prevalence (%)
Whole population	1.96	2.35	1.28
Only index persons	2.22	2.62	1.48
Median age at first event (years)
Whole population	82.30	83.00	81.09
Only index persons	82.63	83.30	81.39

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8916	4219	4697
Unadjusted period prevalence (%)	1.84	1.50	2.15
Median age at first event (years)	80.76	80.70	80.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8621: Matched controls
72785

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R53

ICD-10 Finland

Malaise and fatigue

2.6

321.3

2809

11578

F05.1

ICD-10 Finland

Delirium superimposed on dementia

973.9

320.6

333

SPAT1216

SPAT

Assessment of functional ability

3.1

307.7

2638

9167

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

307.7

722

F03

ICD-10 Finland

Unspecified dementia

48.7

307.7

1867

411

N05AH04

ATC

quetiapine; oral

6.6

307.7

2211

3603

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

622.2

307.7

553

N06DX01

ATC

memantine; oral

559.3

307.7

5629

244

SPAT1245

SPAT

Provision of support and information to patient’s family members

5.8

307.7

1216

2018

R41.0

ICD-10 Finland

Disorientation, unspecified

5.8

307.7

722

1125

G30.8

ICD-10 Finland

Other Alzheimer disease

138.4

307.7

1774

136

N06DA04

ATC

galantamine; oral

208.4

307.7

1247

G30.1

ICD-10 Finland

Alzheimer disease with late onset

146.0

307.7

4160

462

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

307.7

3687

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

7.1

307.7

2187

3337

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

955.1

307.7

820

N05AX08

ATC

risperidone; systemic

21.2

307.7

2942

1737

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

1348.8

307.7

1348

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

268.4

307.7

2425

106

G30.0

ICD-10 Finland

Alzheimer disease with early onset

215.4

307.7

594

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.9

307.7

1528

3771

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

764.0

307.7

3964

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.3

307.7

1708

5016

F0019, G301,

ICD-10 Finland

+∞

307.7

792

G30

ICD-10 Finland

Alzheimer disease

161.8

307.7

688

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

129.6

307.7

2472

225

N05BA04

ATC

oxazepam; oral

2.9

307.7

3040

11356

SPAT1053

SPAT

Memory test

5.3

307.7

3669

8901

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.9

307.7

2455

8884

WYA20

NOMESCO Finland

Home visit

8.7

307.7

462

471

N06DA02

ATC

donepezil; oral

288.7

307.7

3934

211

P70

ICPC

Dementia

45.3

307.7

1256

273

F06.7

ICD-10 Finland

Mild cognitive disorder

16.3

307.7

822

469

N06DA03

ATC

rivastigmine; oral, transdermal

280.4

307.7

2585

111

SPAT1234

SPAT

Support of social functional capacity

5.4

307.7

1329

2378

F05.9

ICD-10 Finland

Delirium, unspecified

49.1

307.7

373

P20

ICPC

Memory disturbance

9.8

307.7

4208

6427

SPAT1254

SPAT

Administration of medicine

2.8

307.7

2223

7941

F009, G309,

ICD-10 Finland

+∞

307.7

467

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

298.7

3775

18247

N03AG01

ATC

valproic acid; systemic, rectal

5.3

281.2

634

1079

F01.9

ICD-10 Finland

Vascular dementia, unspecified

22.7

277.1

228

A28

ICPC

Limited function/disability NOS

2.3

254.9

2726

12087

N05AH03

ATC

olanzapine; systemic

5.8

245.7

498

765

F0009, G300,

ICD-10 Finland

+∞

243.2

248

N06AX11

ATC

mirtazapine; oral

2.2

242.8

3019

14200

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.7

241.7

1608

5694

F00

ICD-10 Finland

Dementia in Alzheimer disease

50.6

230.6

153

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

220.1

2167

9182

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.5

213.3

815

2081

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

213.0

2680

12537

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

613.5

202.6

213

Z75.5

ICD-10 Finland

Holiday relief care

7.7

200.3

306

345

AA1AD

NOMESCO Finland

CT of head and brain

2.0

192.7

3097

15765

N06AB10

ATC

escitalopram; oral

2.7

188.5

1240

4326

SPAT1101

SPAT

Orthostatic test

3.2

187.9

831

2324

N05AD01

ATC

haloperidol; systemic

4.1

181.5

543

1162

F0029, G308,

ICD-10 Finland

+∞

181.2

185

SPAT1304

SPAT

Counselling and guidance related to ageing

2.5

178.8

1356

5061

U04

ICPC

Incontinence urine

3.1

177.0

845

2471

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

+∞

175.3

179

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.3

168.0

701

1887

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

165.1

3468

19090

N02AA05

ATC

oxycodone; systemic

2.0

165.1

2293

10955

SPAT1229

SPAT

Assessment of need for aid

2.6

164.0

1164

4198

F0014, G301,

ICD-10 Finland

1501.2

162.3

168

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

6.5

162.1

289

388

SPAT1360

SPAT

Extensive global examination

2.8

161.8

915

2938

N02BE01

ATC

paracetamol; systemic, rectal

2.2

160.6

7221

50807

R41.3

ICD-10 Finland

Other amnesia

4.4

159.7

438

875

SPAT1172

SPAT

Guidance concerning hydration

3.8

155.7

513

1177

SPAT1301

SPAT

No procedures

1.9

153.2

3099

16751

N06AX26

ATC

vortioxetine; oral

4.2

152.9

452

957

TAB00

NOMESCO Finland

Lumbar puncture

4.8

150.0

365

660

F001, G301,

ICD-10 Finland

669.6

148.7

156

N05BA06

ATC

lorazepam; systemic, sublingual

3.1

148.4

696

2008

S72.0

ICD-10 Finland

Fracture of neck of femur

2.8

145.4

824

2643

SPAT1252

SPAT

Overall medication plan or its review

2.6

143.8

949

3292

A06AD11

ATC

lactulose; oral

2.0

143.8

2190

10731

L28

ICPC

Limited function/disability (L)

1.9

135.6

2201

10987

F05.8

ICD-10 Finland

Other delirium

45.7

134.4

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

1205.7

133.9

139

SPAT1246

SPAT

Screening of depression or other psychiatric problem

5.6

133.9

276

429

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

1185.8

131.9

137

A04

ICPC

Weakness/tiredness general

2.1

129.9

1569

7041

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

16.4

128.9

121

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

127.3

1713

7991

I95.1

ICD-10 Finland

Orthostatic hypotension

2.8

123.4

672

2104

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

3.2

123.4

549

1531

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

121.7

1839

8917

N06AB04

ATC

citalopram; systemic

2.0

120.7

1742

8311

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.3

117.4

1083

4356

SPAT1263

SPAT

Sampling

1.7

116.4

3474

20619

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.3

113.9

1026

4082

F00, F03,

ICD-10 Finland

+∞

106.6

109

S06.0

ICD-10 Finland

Concussion

2.3

106.2

966

3854

S01.0

ICD-10 Finland

Open wound of scalp

2.3

105.2

871

3337

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

103.6

1557

7490

SPAT1251

SPAT

Organisation of medication

2.8

98.0

532

1658

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

95.6

2643

15172

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

51.9

92.2

E86

ICD-10 Finland

Volume depletion

3.2

92.0

406

1124

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

91.1

1186

17043

AXX01, ,

SPAT

3.3

90.9

376

1000

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.3

89.1

193

314

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

2.3

88.4

780

3062

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

88.2

1654

8485

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

85.7

2683

15805

SPAT1167

SPAT

Insertion of urinary catheter

2.6

84.3

526

1760

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.1

82.7

942

4086

N06AB06

ATC

sertraline; oral

2.4

82.4

613

2231

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

+∞

82.1

F0011, G301,

ICD-10 Finland

+∞

81.1

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

12.4

80.0

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.0

79.5

379

1097

R55

ICD-10 Finland

Syncope and collapse

1.9

79.5

1290

6312

LAITO, ,

NOMESCO Finland

23.7

79.1

W19

ICD-10 Finland

Unspecified fall

2.0

78.1

952

4229

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

45.0

77.9

J01CA08

ATC

pivmecillinam; oral

1.6

77.2

2945

18077

130

Kela drug reimbursment

Malignant tumour

0.3

77.2

187

5548

N05AD03

ATC

melperone; systemic

4.3

75.6

211

426

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

75.5

622

2366

SPAT1262

SPAT

Handing over of treatment supplies

1.7

74.2

1621

8640

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

73.5

560

2058

N30.0

ICD-10 Finland

Acute cystitis

1.8

73.2

1417

7296

S70.0

ICD-10 Finland

Contusion of hip

2.5

72.9

482

1658

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

71.7

632

2473

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

321.8

70.9

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

2.4

69.0

502

1805

SPAT1139

SPAT

Nutrition survey

2.8

68.8

377

1178

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.5

68.7

457

1575

F009, F03,

ICD-10 Finland

+∞

67.4

N07AA05, ,

ATC

+∞

65.4

F22.0

ICD-10 Finland

Delusional disorder

5.0

65.4

149

254

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

63.8

302

870

F01.2

ICD-10 Finland

Subcortical vascular dementia

14.5

63.2

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

15.9

63.1

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

61.2

634

2643

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

60.5

2839

17992

R42

ICD-10 Finland

Dizziness and giddiness

1.5

59.8

2200

13235

R4110

NOMESCO Finland

Physiotherapy

0.6

58.7

958

13204

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.9

58.5

302

913

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

517.5

57.8

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.6

57.8

203

485

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.4

57.7

326

6449

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

57.1

2303

14106

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

5.5

56.7

117

182

H02AB02

ATC

dexamethasone; systemic

0.3

56.5

191

4782

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

55.7

F0024, G308,

ICD-10 Finland

+∞

54.7

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.3

54.5

440

1655

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

53.8

366

1274

A10AB05

ATC

insulin aspart; parenteral

2.0

52.3

668

3000

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.7

51.8

302

974

Z29

ICPC

Social problem NOS

3.3

51.8

205

530

R1250

NOMESCO Finland

Evaluation of functional capability

3.6

51.6

178

420

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.7

51.3

125

226

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

51.1

593

2574

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.5

51.0

182

440

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

85.0

50.9

F0012, G301,

ICD-10 Finland

+∞

50.8

WX402

NOMESCO Finland

General anaesthesia

0.4

50.0

349

6369

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

49.2

1002

5190

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.4

48.9

372

1363

F002, G308,

ICD-10 Finland

225.7

48.7

XA800

NOMESCO Finland

Neuropsychological investigation

3.4

48.2

184

465

SPAT1125

SPAT

Stoma care and guidance

2.8

47.3

251

771

SPAT1307

SPAT

Psychosocial counselling and guidance

3.1

47.2

207

570

Z2221

NOMESCO Finland

Medical doctor

0.6

47.2

984

12837

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

423.2

47.2

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

46.9

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.7

46.4

268

860

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

45.2

801

10904

J01DB01

ATC

cefalexin; oral

1.4

45.1

5777

42994

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

44.7

825

4151

C10AA01

ATC

simvastatin; oral

1.4

43.8

4424

31581

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

388.9

43.3

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

388.9

43.3

SPAT1260

SPAT

Consultation of another employee

1.6

43.3

1380

7969

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.6

42.9

259

851

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

135.8

42.7

F21, ,

ICPC

3.9

42.6

132

289

Z03

ICPC

Housing/neighbourhood problem

5.3

42.4

144

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

42.2

1175

6575

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

41.6

699

3419

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

+∞

41.0

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

3.1

41.0

183

510

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

19.1

40.9

G31.0

ICD-10 Finland

Circumscribed brain atrophy

7.3

40.6

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

40.4

3029

20522

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

17.9

39.9

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

20.6

39.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

39.0

1217

6978

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

38.9

1406

16386

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

38.0

1352

7975

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

37.8

3105

21283

A29

ICPC

General symptom/complaint other

1.6

37.5

1048

5858

J01EA01

ATC

trimethoprim; systemic

1.4

37.4

2249

14643

R44.3

ICD-10 Finland

Hallucinations, unspecified

6.1

36.5

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

36.2

884

4780

F0022, G308,

ICD-10 Finland

+∞

36.1

F0021, G308,

ICD-10 Finland

+∞

36.1

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

35.7

750

3901

ZXD10

NOMESCO Finland

Scheduled procedure

0.7

35.6

1915

20859

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.0

35.3

411

1783

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.6

35.1

938

11673

SPAT1284

SPAT

Extensive health certificate

2.8

35.0

190

591

-2, ,

ICPC

4.1

34.8

100

207

E0000UV, ,

ATC

1.4

34.5

2774

18879

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.4

34.2

250

900

F0013, G301,

ICD-10 Finland

+∞

34.2

P29

ICPC

Psychological sympt/compl other

2.7

34.0

196

629

SPAT1310

SPAT

Counselling related to known health issue

1.4

33.9

2198

14446

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.6

33.0

664

8833

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

33.0

3495

24727

L82

ICD-10 Finland

Seborrhoeic keratosis

0.6

32.9

588

8057

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

8.1

32.8

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

32.8

1886

12143

Z28

ICPC

Limited function/disability (Z)

4.9

32.5

133

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

104.6

32.3

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

+∞

32.2

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.0

32.0

379

1653

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

31.4

551

2725

-, ,

ICD-10 Finland

2.4

31.2

222

790

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

31.1

311

1276

P04

ICPC

Feeling/behaving irritable/angry

9.7

30.9

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.8

30.7

160

487

TPH04

NOMESCO Finland

Cathetrisation of vein

0.7

30.5

915

11156

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

29.6

284

1147

N06AX16

ATC

venlafaxine; oral

1.7

29.5

532

2652

SPAT1050

SPAT

Extensive neurological examination

2.6

29.0

182

610

A04AA02

ATC

granisetron; systemic, transdermal

0.3

28.9

2120

Z60.8

ICD-10 Finland

Other problems related to social environment

6.2

28.8

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

264.8

28.8

G72.8

ICD-10 Finland

Other specified myopathies

2.6

28.5

176

586

Z51.5

ICD-10 Finland

Palliative care

1.5

28.2

873

4977

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.6

27.6

770

9551

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.9

27.4

130

376

F009, G301,

ICD-10 Finland

+∞

27.3

F0024, G301,

ICD-10 Finland

+∞

27.3

SPAT1325

SPAT

Vaccination

1.3

27.2

2954

20808

SPAT1104

SPAT

Monitoring of emergency patient

1.7

27.1

548

2817

R44.1

ICD-10 Finland

Visual hallucinations

4.6

26.8

121

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

10.9

26.5

A10AE04

ATC

insulin glargine; parenteral

1.6

26.4

746

4163

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

26.1

1461

9319

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.6

25.8

554

7292

Z2445

NOMESCO Finland

Psychologist

3.1

25.7

113

313

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

25.7

128

381

E000001, ,

ATC

1.4

25.6

1296

8121

N29

ICPC

Neurological sympt/complt other

2.6

25.4

150

488

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.8

25.4

135

416

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

+∞

25.4

N03AX14

ATC

levetiracetam; systemic

2.3

25.2

189

689

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.7

25.1

135

419

WX002

NOMESCO Finland

Sedation and analgesia

0.7

25.0

802

9688

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.7

24.8

136

426

W06

ICD-10 Finland

Fall involving bed

3.1

24.8

109

302

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

24.8

395

1899

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.2

24.7

1504

Y94.1

ICD-10 Finland

Accident in connection with service housing

11.3

24.4

F0004, G300,

ICD-10 Finland

+∞

24.4

H02AA02

ATC

fludrocortisone; oral

3.2

24.4

101

270

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

38.7

24.4

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

3.4

24.3

220

P05

ICPC

Senility, feeling/behaving old

3.5

24.1

205

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

24.1

1425

15494

HA1RA, ,

SPAT

0.1

24.0

688

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.2

23.9

1442

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.4

23.9

125

2582

WX408

NOMESCO Finland

General anesthesy, balanced

0.7

23.5

964

11140

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

23.5

1262

7981

F01

ICD-10 Finland

Vascular dementia

6.7

23.3

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

23.3

217

867

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

23.2

849

5005

Z3226

NOMESCO Finland

Physiotherapist

0.7

23.2

700

8568

R74

ICPC

Upper respiratory infection acute

0.6

22.7

506

6614

JN4AD

NOMESCO Finland

Body CT examination

0.6

22.3

328

4755

F0023, G308,

ICD-10 Finland

203.2

22.1

Z51.88

ICD-10 Finland

Other specified medical care

2.3

22.1

176

660

F01.0

ICD-10 Finland

Vascular dementia of acute onset

57.1

22.0

L75

ICPC

Fracture: femur

2.3

21.8

167

615

R54

ICD-10 Finland

Senility

3.2

21.8

232

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.2

21.7

121

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.6

21.7

528

6769

F06.0

ICD-10 Finland

Organic hallucinosis

39.5

21.5

G04CB01

ATC

finasteride; oral

1.4

21.4

1396

9096

SPAT1138

SPAT

Guidance concerning bowel function

2.4

21.2

155

560

XF400

NOMESCO Finland

ECG with 12 standard connections

0.7

21.2

888

10240

Z08

ICPC

Social welfare problem

3.3

21.1

215

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

21.1

1303

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.3

21.1

1561

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

70.6

21.0

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

+∞

20.5

F0019, G309,

ICD-10 Finland

+∞

20.5

G04CA02

ATC

tamsulosin; oral

1.3

20.4

2555

18157

ZX120

NOMESCO Finland

Intravenous

0.6

20.3

296

4307

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.9

20.3

246

1083

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

6.0

20.3

SPAT1312

SPAT

General health counselling

1.3

20.3

1987

13696

XF606, ,

SPAT

3.7

20.2

151

SPAT1281

SPAT

Other administrative function

1.6

20.2

519

2832

TPH07

NOMESCO Finland

Cathetrisation of artery

0.6

20.2

433

5715

N05AB03

ATC

perphenazine; systemic, rectal

2.2

20.1

175

681

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.2

20.1

222

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

20.1

260

1171

C03DA01

ATC

spironolactone; oral

0.7

20.1

715

8497

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.7

20.0

111

351

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

2.1

19.9

204

846

C04AE01

ATC

ergoloid mesylates; systemic

2.8

19.8

105

324

R50.9

ICD-10 Finland

Fever, unspecified

1.4

19.8

1050

6614

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

19.7

193

787

Y94.0

ICD-10 Finland

Accident at home

2.2

19.7

167

643

A04AA01

ATC

ondansetron; systemic, rectal

0.5

19.7

173

2937

SPAT1255

SPAT

Intravenous administration of medicine

1.6

19.6

514

2817

R11

ICD-10 Finland

Nausea and vomiting

1.5

19.6

640

3681

N07AA06, ,

ATC

+∞

19.5

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

7.7

19.3

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

4.9

19.2

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

65.0

19.2

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

3.5

19.2

161

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

93.1

19.1

N02AX02

ATC

tramadol; systemic, rectal

0.8

19.1

2427

24035

ZXE00

NOMESCO Finland

One hour or less

0.8

19.1

1945

19763

N99

ICPC

Neurological disease other

2.9

19.0

270

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.7

19.0

1217

13155

N05AH02

ATC

clozapine; systemic

5.2

19.0

C10AX09

ATC

ezetimibe; oral

0.6

18.8

493

6230

GD1AA, ,

SPAT

0.3

18.7

1501

R33

ICD-10 Finland

Retention of urine

1.4

18.7

898

5558

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

18.7

287

1365

L15

ICPC

Knee symptom/complaint

0.7

18.7

852

9706

Z11

ICPC

Compliance/being ill problem

3.5

18.7

164

SPAT1313

SPAT

Guidance and counselling related to accident prevention

3.3

18.6

181

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

40.6

18.6

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

18.4

391

2037

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

5.4

18.3

EB1VA, ,

NOMESCO Finland

0.5

18.2

163

2750

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

4.4

18.2

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

18.2

1370

14487

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

18.2

1530

WZC30

NOMESCO Finland

Teaching

0.7

18.1

492

6170

L01BC06

ATC

capecitabine; oral

0.3

18.0

1381

JN4BD

NOMESCO Finland

Extensive body CT

0.6

18.0

411

5353

L08

ICPC

Shoulder symptom/complaint

0.7

18.0

742

8601

A10AE05

ATC

insulin detemir; parenteral

1.7

17.8

369

1909

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

17.8

744

8609

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

17.8

3324

24606

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.0

17.7

183

762

N05AX12

ATC

aripiprazole; systemic

3.5

17.6

154

SPAT1014

SPAT

Treatment of eyes

2.1

17.6

169

685

F000, G300,

ICD-10 Finland

+∞

17.6

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

17.6

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.1

17.4

854

A98

ICPC

Health maint/preventive medicine

1.2

17.3

6145

48503

SPAT1097

SPAT

Recording of ECG

1.3

17.3

1180

7722

P28

ICPC

Limited function/disability (P)

4.2

17.2

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.1

16.8

506

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

0.6

16.7

374

4897

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.4

16.6

1780

R06.0

ICD-10 Finland

Dyspnoea

0.8

16.5

1595

16376

N05CD07

ATC

temazepam; oral

1.3

16.5

1255

8336

S18

ICPC

Laceration/cut

0.8

16.5

2441

23885

F32

ICD-10 Finland

Depressive episode

2.0

16.5

179

760

N28

ICPC

Limited function/disability (N)

2.3

16.3

129

483

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

16.3

1127

7382

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.5

16.3

143

2428

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.1

16.3

197

G91.0

ICD-10 Finland

Communicating hydrocephalus

3.7

16.2

118

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.5

16.1

183

2862

L57.0

ICD-10 Finland

Actinic keratosis

0.7

16.1

658

7652

SDA03

NOMESCO Finland

Periodontal treatment

0.8

16.1

1058

11426

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.5

16.1

105

361

H04AA01

ATC

glucagon; nasal, parenteral

3.0

16.0

208

N06AX21

ATC

duloxetine; oral

1.5

15.8

525

3031

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

15.7

489

2784

S22.3

ICD-10 Finland

Fracture of rib

1.5

15.6

488

2782

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

15.5

304

1552

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

143.8

15.4

K08.3

ICD-10 Finland

Retained dental root

1.5

15.3

473

2688

T93

ICPC

Lipid disorder

0.5

15.2

141

2351

G04BD07

ATC

tolterodine; oral

1.5

15.2

492

2825

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

15.1

634

3826

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

15.0

235

1125

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.5

15.0

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

15.0

1491

R45.1

ICD-10 Finland

Restlessness and agitation

5.9

14.9

EB1AA, ,

SPAT

0.4

14.9

1423

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.7

14.8

392

4953

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.0

14.8

154

644

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.6

14.8

304

4060

R01AD58

ATC

fluticasone, combinations; nasal

0.6

14.7

380

4824

M04AA01

ATC

allopurinol; systemic

0.7

14.7

923

10043

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.7

14.6

467

5684

F0001, G300,

ICD-10 Finland

+∞

14.6

F0021, G301,

ICD-10 Finland

+∞

14.6

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.0

14.6

151

630

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.6

14.6

306

1589

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

7.2

14.6

Z00.0

ICD-10 Finland

General medical examination

1.3

14.5

1258

8492

G03CA04

ATC

estriol; systemic, vaginal

1.4

14.5

751

4702

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

14.5

128

503

XF402

NOMESCO Finland

ECG with work load test

0.7

14.4

432

5323

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

135.3

14.4

SPAT1111

SPAT

Planning of analgesia

2.4

14.4

339

Z75.0

ICD-10 Finland

Medical services not available in home

4.2

14.4

SPAT1285

SPAT

Provision of consultation response

1.6

14.3

359

1948

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.4

14.3

129

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.5

14.2

409

2292

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

14.1

771

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

14.1

191

Z01.7

ICD-10 Finland

Laboratory examination

0.7

14.1

433

5308

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

4.4

14.0

SCA02

NOMESCO Finland

Preventive oral health care

1.5

14.0

405

2271

T03

ICPC

Loss of appetite

3.9

14.0

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.7

13.9

391

4880

WX111

NOMESCO Finland

Local infiltration anesthesia

0.4

13.9

1257

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.5

13.8

108

1906

A04AA55

ATC

palonosetron, combinations; systemic

0.1

13.8

476

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

13.7

196

915

F0009, G309,

ICD-10 Finland

+∞

13.7

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.1

13.6

125

499

WF002

NOMESCO Finland

Radical radiotherapy

0.5

13.6

134

2187

G04BD08

ATC

solifenacin; oral

1.4

13.5

559

3365

TQW40, ,

SPAT

0.5

13.4

134

2177

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

3.8

13.4

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

13.3

557

6461

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

13.3

567

3435

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

13.2

1438

14625

K59.0

ICD-10 Finland

Constipation

1.5

13.2

489

2884

C10AA07

ATC

rosuvastatin; oral

0.8

13.2

1300

13370

WW500

NOMESCO Finland

Blood transfusion

0.5

13.2

103

1816

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.3

13.1

1069

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

13.1

2260

16471

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

13.1

707

7872

R05

ICPC

Cough

0.8

13.0

863

9334

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

35.9

13.0

B01AB10

ATC

tinzaparin; parenteral

0.6

13.0

297

3871

M01AC06

ATC

meloxicam; systemic, rectal

1.2

13.0

2181

15849

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.1

12.9

129

532

S06.3

ICD-10 Finland

Focal brain injury

2.3

12.9

101

378

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

0.5

12.9

1689

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

12.9

385

4746

C03CA01

ATC

furosemide; systemic

1.2

12.9

3959

30392

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.8

12.8

205

990

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

12.8

885

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

+∞

12.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

0.8

12.6

1071

11222

R1250, ,

SPAT

2.2

12.6

106

409

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

0.4

12.6

1246

AXX01

NOMESCO Finland

Memory assessment

10.1

12.5

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.3

12.5

1070

4289X

ICD-9 Finland

Heart failure, unspecified

0.2

12.5

462

UJF30

NOMESCO Finland

Ileoscopy through colon

0.6

12.5

267

3532

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

2.0

12.5

142

615

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.0

12.2

137

590

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.1

12.2

420

M25.5

ICD-10 Finland

Pain in joint

0.8

12.2

998

10507

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

12.2

403

4873

R03AK07

ATC

formoterol and budesonide; inhalant

0.7

12.1

597

6746

M02AA07

ATC

piroxicam; topical

1.2

12.1

2767

20671

D07AA02

ATC

hydrocortisone; topical

1.3

12.0

770

4980

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

2.3

12.0

315

AA1AA

NOMESCO Finland

Head X-ray examination

2.6

12.0

219

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

12.0

1023

6883

A10BB12

ATC

glimepiride; oral

1.3

12.0

774

5013

Z3231

NOMESCO Finland

Registered nurse

0.8

12.0

1437

14478

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.7

11.9

200

980

R03BB01

ATC

ipratropium bromide; inhalant

0.6

11.9

266

3482

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.7

11.8

200

982

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.7

11.8

648

7204

A27

ICPC

Fear of other disease NOS

1.5

11.7

316

1746

R03AC02

ATC

salbutamol; inhalant

0.8

11.7

2714

25699

R44.0

ICD-10 Finland

Auditory hallucinations

4.0

11.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.5

11.7

334

1869

PJA12

NOMESCO Finland

Sentinel node biopsy

0.6

11.6

173

2500

WX320

NOMESCO Finland

Spinalanesthesy

0.8

11.6

1179

12104

L12

ICPC

Hand/finger symptom/complaint

0.7

11.6

473

5512

F009, G308,

ICD-10 Finland

109.9

11.6

M01AH05

ATC

etoricoxib; oral

0.8

11.5

2430

23210

S01

ICD-10 Finland

Open wound of head

2.2

11.5

348

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

11.5

212

1067

S21

ICPC

Skin texture symptom/complaint

0.7

11.5

559

6331

S29

ICPC

Skin symptom/complaint other

0.8

11.3

802

8608

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.9

11.3

134

589

K90

ICPC

Stroke/cerebrovascular accident

1.6

11.3

264

1412

XQ858, ,

SPAT

3.6

11.2

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

11.2

661

4222

P19

ICPC

Drug abuse

5.6

11.2

K85

ICPC

Elevated blood pressure

0.8

11.2

848

9023

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

11.2

327

1840

L03AA02

ATC

filgrastim; parenteral

0.3

11.2

909

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.3

11.1

843

R02

ICPC

Shortness of breath/dyspnoea

0.7

11.1

598

6673

S32.5

ICD-10 Finland

Fracture of pubis

2.1

11.1

392

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

11.1

409

EB4VA, ,

NOMESCO Finland

0.4

11.0

1331

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

11.0

935

6288

J01MA02

ATC

ciprofloxacin; systemic

1.2

11.0

3037

23010

A10BK01

ATC

dapagliflozin; oral

0.6

10.9

173

2461

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.4

10.9

1024

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

10.9

471

2861

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.4

10.9

972

EB1SA, ,

SPAT

0.3

10.8

751

N18

ICPC

Paralysis/weakness

1.8

10.8

153

713

K80

ICPC

Cardiac arrhythmia NOS

0.6

10.8

266

3411

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.3

10.8

943

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

10.7

636

4065

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.2

10.7

706

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

10.7

F0001, G301,

ICD-10 Finland

+∞

10.7

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

0.5

10.7

117

1845

A10BK03

ATC

empagliflozin; oral

0.7

10.7

271

3454

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

10.7

253

W18

ICD-10 Finland

Other fall on same level

2.4

10.7

248

F01.1

ICD-10 Finland

Multi-infarct dementia

101.5

10.6

Z27

ICPC

Fear of a social problem

4.3

10.6

KMAK, ,

NOMESCO Finland

1.2

10.6

2318

17204

WF004

NOMESCO Finland

Palliative radiotherapy

0.4

10.6

948

L17

ICPC

Foot/toe symptom/complaint

0.8

10.6

1302

13108

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.6

10.5

183

2542

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.6

10.5

220

2925

R45.5

ICD-10 Finland

Hostility

19.3

10.5

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

10.5

120

1867

S82

ICPC

Naevus/mole

0.7

10.5

405

4766

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

10.4

356

2068

WX110, ,

SPAT

0.4

10.4

1124

P15

ICPC

Chronic alcohol abuse

2.4

10.4

256

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

10.4

148

692

N03AX18

ATC

lacosamide; systemic

3.8

10.4

N05CF01

ATC

zopiclone; oral

1.2

10.3

2722

20512

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

10.3

368

4392

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

10.3

158

WYA20, ,

SPAT

3.0

10.3

126

B01AC07

ATC

dipyridamole; systemic

1.3

10.3

672

4359

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

10.2

2726

20558

J01CA04

ATC

amoxicillin; systemic

1.2

10.2

5183

41069

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

10.2

1088

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.9

10.1

134

612

M05BA02

ATC

clodronic acid; systemic

0.1

10.1

311

R03DA04

ATC

theophylline; systemic, rectal

0.7

10.0

375

4438

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.5

10.0

1610

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.4

10.0

995

S28

ICPC

Limited function/disability (S)

2.5

10.0

200

SPAT1127

SPAT

Enema

2.1

9.9

348

S72.2

ICD-10 Finland

Subtrochanteric fracture

2.1

9.9

371

WX892

NOMESCO Finland

Monitored bed care

0.7

9.9

283

3518

R01AD59

ATC

mometasone, combinations; nasal

0.2

9.9

378

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

9.8

280

1568

HA1AA

NOMESCO Finland

X-ray mammography

0.6

9.8

172

2379

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

9.8

F0014, G309,

ICD-10 Finland

+∞

9.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

0.6

9.7

124

1867

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

93.0

9.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.4

9.7

908

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

2.3

9.7

281

G04BD10

ATC

darifenacin; oral

2.4

9.6

234

L03

ICPC

Low back symptom/complaint

0.8

9.6

1043

10654

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

9.6

550

I95.9

ICD-10 Finland

Hypotension, unspecified

1.8

9.6

133

617

A01

ICPC

Pain general/multiple sites

1.3

9.6

583

3742

ICB01, ,

SPAT

4.1

9.6

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.6

9.5

236

3022

90621, ,

NOMESCO Finland

3.0

9.5

114

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

0.7

9.5

261

3269

E979A

ICD-9 Finland

DAMAGE OCCURRED BY ANOTHER OR SPECIFIED WAY

3.6

9.5

SPAT1240

SPAT

Therapeutic discussion

1.5

9.4

288

1637

A05

ICPC

Feeling ill

1.6

9.4

237

1291

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.9

9.4

133

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.6

9.4

190

982

H02AB07

ATC

prednisone; oral

0.8

9.4

706

7528

ZXE20

NOMESCO Finland

More than three and less than five hours

0.8

9.4

621

6732

Z74.1

ICD-10 Finland

Need for assistance with personal care

13.5

9.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.3

9.3

662

F10.24

ICD-10 Finland

Alcohol depence active use

3.1

9.3

111

A10BH05

ATC

linagliptin; oral

1.4

9.3

458

2846

K03.66

ICD-10 Finland

Tooth plaque

1.4

9.2

345

2041

P99

ICPC

Psychological disorders other

2.4

9.2

218

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

9.2

119

1782

L13

ICPC

Hip symptom/complaint

0.8

9.2

850

8836

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1.9

9.1

108

476

A11CC03

ATC

alfacalcidol; systemic

0.4

9.1

1040

R4110, ,

SPAT

0.7

9.1

228

2909

WX100

NOMESCO Finland

Conjunctival surface anesthesia

0.8

9.1

803

8394

L03AA13

ATC

pegfilgrastim; parenteral

0.5

9.0

1125

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.2

8.9

357

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

46.5

8.9

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

8.9

136

1947

WX722

NOMESCO Finland

PEEP

0.6

8.9

121

1787

L76

ICPC

Fracture: other

1.6

8.9

214

1156

WX212

NOMESCO Finland

Femoral plexus blockade

1.6

8.8

179

926

Z50.1

ICD-10 Finland

Other physical therapy

0.6

8.8

152

2113

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.6

8.8

157

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.7

8.8

160

804

Z74.2

ICD-10 Finland

Need for assistance at home and no other household member able to render care

10.3

8.8

F0289, G318,

ICD-10 Finland

+∞

8.8

F0010, G308,

ICD-10 Finland

+∞

8.8

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.5

8.8

266

1511

F0022, G301,

ICD-10 Finland

84.5

8.8

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.3

8.7

728

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.2

8.7

556

DFF00

NOMESCO Finland

Pure tone audiometry

0.7

8.7

421

4776

K86

ICPC

Hypertension uncomplicated

0.8

8.7

656

6994

N80

ICPC

Head injury other

1.9

8.7

110

497

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.7

8.6

152

758

H02AB06

ATC

prednisolone; systemic

0.9

8.6

2938

27196

Z01.2

ICD-10 Finland

Dental examination

0.8

8.6

1472

14389

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

8.6

335

A97

ICPC

No disease

0.8

8.6

745

7805

G20

ICD-10 Finland

Parkinson disease

1.5

8.6

243

1362

A69.2

ICD-10 Finland

Lyme disease

0.6

8.5

109

1639

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

2.0

8.5

405

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

8.5

1079

10854

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.3

8.5

XF404

NOMESCO Finland

Ambulatory ECG

0.7

8.5

388

4439

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

0.2

8.5

346

WZC30, ,

SPAT

0.6

8.4

121

1762

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

8.4

156

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

4.7

8.4

F38

ICPC

Eye, Other laboratory test NEC

0.2

8.4

459

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

3.0

8.4

100

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.8

8.4

117

545

N07

ICPC

Convulsion/seizure

7.0

8.4

D19

ICPC

Teeth/gum symptom/complaint

0.8

8.4

727

7618

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.5

8.3

235

1315

F16

ICPC

Eyelid symptom/complaint

0.5

8.3

101

1540

I50.1

ICD-10 Finland

Left ventricular failure

0.7

8.3

341

3971

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.3

8.3

696

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

8.3

875

6033

L01CA04

ATC

vinorelbine; systemic

0.2

8.3

305

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

8.3

213

1169

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.4

8.3

903

M02AA10

ATC

ketoprofen; topical

1.2

8.2

1035

7273

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

3.1

8.2

G04CB02

ATC

dutasteride; oral

1.3

8.2

706

4753

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

6.8

8.2

T68

ICD-10 Finland

Hypothermia

2.9

8.1

111

XG460

NOMESCO Finland

Short time oxymetry

0.4

8.1

850

P12

ICPC

Bedwetting/enuresis

20.3

8.1

N03AF02

ATC

oxcarbazepine; oral

1.7

8.1

152

772

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

8.1

332

2002

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

8.0

329

1982

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

8.0

568

N02BF01

ATC

gabapentin; oral

0.7

8.0

201

2563

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.6

8.0

198

1077

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

1.6

8.0

179

951

S12

ICPC

Insect bite/sting

0.7

8.0

288

3427

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

0.6

8.0

190

2448

X59.0

ICD-10 Finland

Exposure to unspecified factor causing fracture

7.6

7.9

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

4.0

7.9

S20.2

ICD-10 Finland

Contusion of thorax

1.4

7.9

287

1691

R40.2

ICD-10 Finland

Coma, unspecified

2.1

7.9

295

S01.3

ICD-10 Finland

Open wound of ear

2.1

7.9

312

SCF02

NOMESCO Finland

Preventive oral care by dental hygienist

1.8

7.9

120

575

J01MA06

ATC

norfloxacin; oral

1.2

7.9

927

6468

D06BB10

ATC

imiquimod; topical

0.6

7.9

175

2288

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

7.8

546

N05AN01

ATC

lithium; oral

2.2

7.8

241

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

0.7

7.8

231

2850

F0002, G300,

ICD-10 Finland

+∞

7.8

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.4

7.8

711

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

7.8

1445

10538

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

7.8

678

4571

P71

ICPC

Organic psychosis other

23.2

7.8

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

7.7

131

647

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.6

7.7

164

2168

H01

ICPC

Ear pain/earache

0.7

7.7

242

2954

F01.8

ICD-10 Finland

Other vascular dementia

13.7

7.7

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

0.5

7.7

1407

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

0.5

7.7

1253

G04CA01

ATC

alfuzosin; oral

1.2

7.7

996

7019

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

7.7

168

2205

R4190

NOMESCO Finland

Nutritional therapy

0.4

7.7

681

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

7.6

107

500

ZX090

NOMESCO Finland

Other technic of radiotherapy

0.5

7.6

978

L99

ICPC

Musculoskeletal disease other

1.7

7.6

126

619

H25.1

ICD-10 Finland

Senile nuclear cataract

1.1

7.6

3304

25682

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.2

7.6

239

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

4.5

7.6

SPAT1042

SPAT

Guidance concerning balance maintenance

2.4

7.6

191

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.9

7.5

2069

19503

R5140

NOMESCO Finland

Monitoring the use of the aid

0.7

7.5

320

3703

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.7

7.5

146

749

WX872

NOMESCO Finland

Intensive care

0.6

7.5

147

1978

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

7.5

528

5679

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.4

1740

12931

F0020, G301,

ICD-10 Finland

28.2

7.4

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.3

7.4

WX199

NOMESCO Finland

Other local analgesia

0.6

7.4

100

1477

S09.9

ICD-10 Finland

Unspecified injury of head

1.9

7.4

420

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

7.4

737

5048

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

0.4

7.4

815

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

12.2

7.4

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.4

7.4

399

2519

R26

ICD-10 Finland

Abnormalities of gait and mobility

3.4

7.4

SPAT1394

SPAT

Counselling and guidance related to living conditions

3.4

7.4

SPAT1165

SPAT

Peritoneal dialysis

3.5

7.3

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

7.3

205

3639

FHL

Other measure in this category

3.2

7.3

XKD00

NOMESCO Finland

Uroflowmetry

1.2

7.3

1414

10348

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

0.4

7.3

856

R63.4

ICD-10 Finland

Abnormal weight loss

1.4

7.3

263

1551

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

0.1

7.2

224

SPAT1154

SPAT

Insertion or removal of subcutaneous medicine capsule

3.3

7.2

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

1.5

7.2

227

1302

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

9.9

7.2

OAB76

NOMESCO Finland

General guidance on nutrition and food

9.9

7.2

L02BB03

ATC

bicalutamide; oral

0.6

7.2

167

2163

NG1AA, ,

SPAT

0.4

7.2

636

R21

ICPC

Throat symptom/complaint

0.7

7.2

383

4281

S00.3

ICD-10 Finland

Superficial injury of nose

2.4

7.2

164

N17

ICPC

Vertigo/dizziness

1.2

7.2

877

6141

N05AA02

ATC

levomepromazine; systemic

1.5

7.2

200

1118

XCW10

NOMESCO Finland

Assessment of vision

0.3

7.2

505

K59.09

ICD-10 Finland

Constipation, unspecified

1.3

7.1

504

3307

J01DA06

ATC

[U] cefuroxime

0.8

7.1

539

5746

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

38.0

7.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

0.6

7.1

1330

N88

ICPC

Epilepsy

3.1

7.1

E44.1

ICD-10 Finland

Mild protein-energy malnutrition

6.8

7.1

B34.9

ICD-10 Finland

Viral infection, unspecified

1.8

7.1

102

482

GD1LA

NOMESCO Finland

0.4

7.0

616

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

0.8

7.0

763

7803

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

2.7

7.0

121

-1, ,

ICD-10 Finland

1.8

7.0

422

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.2

7.0

220

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.3

6.9

188

C09CA06

ATC

candesartan; oral

0.8

6.9

1030

10217

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

0.5

6.9

921

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.9

1712

12770

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

21.1

6.9

IGV01

NOMESCO Finland

Psychiatric network contact

6.1

6.9

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.4

6.9

328

2029

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

2.0

6.9

317

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.9

6.9

XQ855, ,

SPAT

2.3

6.9

194

L02BG04

ATC

letrozole; oral

0.6

6.9

155

2019

250, ,

Kela drug reimbursment

0.3

6.9

507

W0A10

NOMESCO Finland

Mapping of psychosocial situation

7.9

6.9

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.8

6.9

437

FXZ00

NOMESCO Finland

Off-pump cardiac operation

0.2

6.8

302

F06.30

ICD-10 Finland

Organic manic syndrome

+∞

6.8

F0024, G309,

ICD-10 Finland

+∞

6.8

F0003, G300,

ICD-10 Finland

+∞

6.8

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

6.8

437

R4120

NOMESCO Finland

Occupational therapy

0.6

6.8

161

2074

N06AX12

ATC

bupropion; oral

1.8

6.8

451

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.3

6.8

453

2951

WX702

NOMESCO Finland

Supraglottic ventilation device

0.6

6.8

1376

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.6

6.7

159

2050

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

0.5

6.7

1222

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.7

6.7

217

2628

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.7

6.7

161

2065

128

Kela drug reimbursment

Cancers of female genital organs

0.3

6.7

536

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

0.7

6.6

177

2225

G04BD04

ATC

oxybutynin; oral, transdermal

1.3

6.6

482

3177

A64

ICPC

General and Unspecified, Encounter/prob initiated by provider

3.6

6.6

359

Kela drug reimbursment

Mirabegroni

2.3

6.6

187

AA1XD

NOMESCO Finland

Other special CT of head and brain

2.8

6.6

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

6.6

142

1867

A91

ICPC

Abnormal result investigation NOS

0.6

6.6

135

1795

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.8

6.6

427

4642

Z59.8

ICD-10 Finland

Other problems related to housing and economic circumstances

4.4

6.6

R18

ICD-10 Finland

Ascites

0.4

6.6

788

B81

ICPC

Anaemia vit B12/folate deficiency

1.4

6.6

312

1931

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.4

6.6

326

2033

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

13.3

6.5

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.6

6.5

138

725

N03AX09

ATC

lamotrigine; oral

1.8

6.5

426

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

0.6

6.5

1329

GD1AD

NOMESCO Finland

Thorax CT examination

0.7

6.5

180

2246

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

0.6

6.5

103

1455

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

6.5

282

3246

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

0.7

6.5

162

2061

S01.8

ICD-10 Finland

Open wound of other parts of head

1.8

6.5

391

A86

ICD-10 Finland

Unspecified viral encephalitis

2.9

6.4

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.2

6.4

200

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

6.4

1849

13940

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

0.6

6.4

117

1597

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.6

6.4

140

742

62670

ICD-8 Finland

Disorders of menstruation, Postmenopausal bleeding

1.7

6.4

101

491

S02.51

ICD-10 Finland

Fracture of tooth, open

0.7

6.4

190

2337

163

Kela drug reimbursment

Abiraterone and enzalutamide

0.3

6.4

473

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

0.5

6.4

1061

115

Kela drug reimbursment

Breast cancer

0.7

6.4

250

2928

M79.6

ICD-10 Finland

Pain in limb

0.9

6.4

1939

18184

F34.1

ICD-10 Finland

Dysthymia

1.8

6.4

467

F32.0

ICD-10 Finland

Mild depressive episode

1.8

6.3

381

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

0.2

6.3

305

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

6.3

195

1116

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

0.6

6.3

140

1828

L89

ICPC

Osteoarthrosis of hip

0.6

6.3

111

1527

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.8

6.3

670

6866

J01FA09

ATC

clarithromycin; systemic

0.8

6.3

1113

10874

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.2

6.3

387

P69

ICPC

Psychological, Other reason for encounter NEC

8.5

6.2

SPAT1109

SPAT

Analgesia with portable analgesic pump

2.2

6.2

192

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

2.6

6.2

114

WX704

NOMESCO Finland

Intubation

0.7

6.2

206

2483

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

6.2

640

X31

ICD-10 Finland

Exposure to excessive natural cold

3.2

6.2

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.7

6.2

179

2212

CS2P4

NOMESCO Finland

Optic nerve head imaging

0.2

6.2

271

T89

ICPC

Diabetes insulin dependent

1.6

6.2

128

670

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

6.2

370

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.5

6.1

1081

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

6.1

290

3296

L90

ICPC

Osteoarthrosis of knee

0.7

6.1

246

2869

S08

ICPC

Skin colour change

0.7

6.1

183

2248

L02BB04

ATC

enzalutamide; oral

0.3

6.1

422

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

19.0

6.1

C10AA02

ATC

lovastatin; oral

1.3

6.1

434

2854

N06AX03

ATC

mianserin; oral

1.4

6.1

263

1604

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.6

6.1

A12AA04

ATC

calcium carbonate; oral

0.4

6.1

658

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

6.1

554

5775

JN4CD

NOMESCO Finland

Very extensive body CT

0.6

6.1

122

1626

L01

ICPC

Neck symptom/complaint

0.8

6.1

466

4955

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

6.0

301

1879

ZY000

NOMESCO Finland

Hospital inpatient

2.7

6.0

101

S97

ICPC

Chronic ulcer skin

1.3

6.0

478

3187

S32.4

ICD-10 Finland

Fracture of acetabulum

2.0

6.0

257

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

6.0

533

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

3398

13446

2.87

307.65

2.1

1.8

1408.70

1146.33

nmol/l

40.72

2354

9801

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

316

122

22.66

307.65

1.0

416.45

238.33

ng/l

8.99

196

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

322

122

23.11

307.65

1.0

57.43

32.43

ng/l

9.07

201

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

322

122

23.11

307.65

1.0

539.15

734.19

ng/l

4.67

191

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2855

12772

2.33

262.99

1.9

1.7

4412191.25

22677319.95

pmol/l

2.44

2176

9922

(3029937) Albumin [Presence] in Urine by Test strip

2892

13648

2.19

227.71

5.4

4.8

0.00

estimate

0.88

727

4411

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3419

18664

1.91

167.73

5.5

4.9

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

372

666

4.88

154.64

1.2

1.3

475.03

626.54

mg/l

3.89

333

636

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4033

23699

1.82

152.08

5.0

4.6

56.34

97.74

ng/l

1.36

3348

19185

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

326

553

5.13

143.97

1.2

1.3

16.85

30.65

e6/l

0.45

283

443

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

326

553

5.13

143.97

1.3

1.4

287.22

877.93

e6/l

1.47

290

469

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

328

578

4.94

138.75

1.2

3.95

3.94

mmol/l

0.03

309

530

(3019150) Specific gravity of Urine by Refractometry

2207

10976

1.94

137.82

5.8

4.9

1.02

kg/l

1.12

173

1892

(3009466) Valproate [Moles/volume] in Serum or Plasma

256

370

5.99

133.66

2.9

3.3

315.00

327.23

umol/l

0.50

190

299

(3015377) Calcium [Moles/volume] in Serum or Plasma

3282

18875

1.76

125.81

2.4

3.3

2.34

2.35

mmol/l

1.59

2664

15812

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1506

7055

1.97

108.81

10.4

9.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5290

35938

1.63

97.52

6.6

5.5

3108.94

1473.87

e6/l

1.95

337

602

(40761535) Cells panel - Urine sediment

1111

4964

2.02

90.43

4.0

3.7

—

(3035350) Ketones [Presence] in Urine by Test strip

3879

24807

1.58

88.63

5.2

4.4

0.00

estimate

0.17

877

5204

(3015736) pH of Urine

3252

19957

1.60

88.46

4.9

4.1

5.93

5.86

0.20

505

(3044290) Cell count panel - Cerebral spinal fluid

254

531

4.13

87.02

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

3837

24716

1.56

83.09

6.2

5.9

0.00

estimate

-0.00

790

4696

(3021960) Folate [Moles/volume] in Serum or Plasma

2502

14653

1.62

80.80

1.7

1.6

20.18

20.03

nmol/l

0.15

2048

12236

(3009261) Glucose [Presence] in Urine by Test strip

3865

25046

1.55

80.66

5.2

4.4

0.00

estimate

0.80

792

4674

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2046

11440

1.67

79.05

2.8

3.1

2.46

2.47

mmol/l

7.96

1767

9670

(3026008) Bacteria identified in Urine by Culture

3282

20625

1.55

77.71

4.0

3.7

—

(40768804) Tissue Pathology biopsy report

1591

20054

0.60

72.22

2.1

2.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3150

20045

1.51

67.77

2.1

2.2

76.99

81.31

nmol/l

13.07

2483

17001

(3023368) Bacteria identified in Blood by Culture

2929

18413

1.52

66.39

3.8

4.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

763

11553

0.51

65.50

1.5

1.6

1.24

1.26

mmol/l

0.35

564

9352

(3024561) Albumin [Mass/volume] in Serum or Plasma

3747

25232

1.45

57.72

3.5

4.4

33.93

33.78

g/l

0.81

3214

22969

(3041096) Erythrocytes [Presence] in Urine by Automated

2095

12636

1.53

55.60

4.6

4.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2718

17392

1.47

53.62

2.3

2.1

263.00

216.96

u/l

1.65

2459

16062

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

794

3785

1.85

51.82

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1180

6387

1.65

49.05

2.6

2.5

5.08

6.12

ug/l

1.38

785

5342

(3033658) Prothrombin time (PT) actual/Normal

1042

13494

0.60

48.69

3.1

4.0

78.12

80.33

1.86

986

13164

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3847

26620

1.40

47.51

4.8

5.9

1.21

mmol/l

1.55

3217

23803

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6211

46711

1.44

46.74

19.8

19.5

30.46

28.86

mg/l

2.54

5360

39281

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4194

29506

1.39

46.57

4.9

6.6

1.22

1.21

mmol/l

7.58

3162

24576

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3597

24782

1.39

44.60

2.4

2.1

90.19

92.46

pmol/l

1.98

1838

12543

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

978

5162

1.68

44.52

3.2

3.9

1.23

1.22

mmol/l

1.05

767

4481

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1804

11009

1.48

43.61

1.9

—

(3014271) Vancomycin [Susceptibility]

186

516

3.09

41.95

3.5

3.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2776

18569

1.39

39.85

2.4

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

348

1357

2.21

39.51

3.8

3.9

31.02

31.33

mg/l

0.05

270

906

(3018405) Lactate [Moles/volume] in Arterial blood

516

2347

1.91

38.64

2.8

3.8

1.47

1.45

mmol/l

0.14

506

2297

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1111

6349

1.55

35.96

5.0

3.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4653

34054

1.33

35.79

3.8

4.0

15.59

15.28

pmol/l

11.45

3820

29611

(3020682) Albumin/Creatinine [Ratio] in Urine

1667

18589

0.70

35.59

3.1

3.7

10.96

10.26

mg/mmol

0.20

1001

11667

(3012516) Albumin [Mass/volume] in Urine

1555

17464

0.70

34.29

2.7

3.2

447.39

349.50

mg/l

0.35

940

11221

(3009508) Creatinine [Moles/volume] in Urine

1561

17467

0.70

33.55

2.6

3.1

6.94

6.60

mmol/l

2.50

1161

14059

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

130

333

3.33

33.44

2.5

2.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

463

2140

1.87

32.96

1.2

—

(4035726) Immunohistochemistry procedure

289

4876

0.48

32.61

1.2

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4837

35854

1.32

32.51

5.3

5.0

—

(3020891) Body temperature

534

2598

1.78

32.20

3.5

4.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4177

30442

1.31

31.19

21.1

22.6

1.36

1.46

inr

5.74

1199

8435

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

770

9750

0.63

30.72

3.5

3.2

2.82

2.56

e6/l

0.43

469

5583

(3013826) Glucose [Moles/volume] in Serum or Plasma

4420

32501

1.30

30.68

4.8

4.7

7.19

6.95

mmol/l

8.02

4154

30564

(3019550) Sodium [Moles/volume] in Serum or Plasma

6348

49134

1.34

30.07

24.0

23.9

139.63

139.35

mmol/l

9.31

5968

47617

(3000492) Spirometry study

173

3429

0.41

29.97

1.4

1.6

—

(40761511) CBC panel - Blood by Automated count

6067

46672

1.33

29.77

21.0

19.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

6350

49178

1.34

29.74

23.9

24.1

4.02

mmol/l

0.16

5952

47577

(3010813) Leukocytes [#/volume] in Blood

6378

49491

1.34

28.95

28.0

28.9

7.39

7.14

e9/l

5.17

5964

47409

(3040151) Glucose [Moles/volume] in Capillary blood

224

832

2.31

28.59

9.0

10.3

7.76

7.28

mmol/l

1.05

182

687

(3009542) Hematocrit [Volume Fraction] of Blood

6373

49478

1.34

28.57

27.9

28.9

37.88

38.36

6.41

5600

45015

(3035941) MCH [Entitic mass]

6373

49483

1.34

28.51

27.9

28.8

30.35

30.41

1.34

6022

48247

(3026361) Erythrocytes [#/volume] in Blood

6373

49484

1.33

28.49

28.0

28.9

4.20

4.29

e12/l

31.07

5960

47391

(3024731) MCV [Entitic volume]

6373

49485

1.33

28.48

27.9

28.8

91.94

92.03

0.72

6025

48249

(3007461) Platelets [#/volume] in Blood

6372

49478

1.33

28.46

28.0

28.9

237.37

235.66

e9/l

1.10

5978

47645

(3000963) Hemoglobin [Mass/volume] in Blood

6373

49492

1.33

28.40

28.2

29.1

126.95

129.43

g/l

30.91

6023

48263

(3022096) Basophils/100 leukocytes in Blood

2224

22934

0.76

26.65

4.5

5.6

0.57

0.61

2.50

1924

20961

(3023410) Appearance of Cerebral spinal fluid

223

3.55

26.53

1.2

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

2293

23524

0.76

26.38

4.4

5.5

60.98

59.89

3.46

1997

21545

(3030981) Hyaline casts [#/volume] in Urine by Automated count

639

3446

1.61

26.19

3.6

2.9

0.45

0.34

e6/l

0.77

629

3388

(3006504) Eosinophils/100 leukocytes in Blood

2300

23560

0.76

26.08

4.4

5.6

2.74

2.78

0.32

1999

21537

(3019069) Monocytes/100 leukocytes in Blood

2318

23684

0.76

25.67

4.9

5.9

8.78

9.01

2.11

2019

21648

(3008152) Bicarbonate [Moles/volume] in Arterial blood

750

4219

1.55

25.63

4.8

6.3

24.37

24.53

mmol/l

0.57

727

4014

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5482

42029

1.28

24.60

4.8

4.9

2.08

2.16

mu/l

1.28

4563

36799

(3002256) Pathology report gross observation

540

7025

0.63

23.82

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

211

3559

0.49

23.59

5.2

6.9

24.07

24.35

mmol/l

0.52

184

3350

(3018418) pH of Serum or Plasma

2486

17435

1.29

22.63

3.1

4.1

7.40

0.48

632

3358

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

889

10353

0.69

22.55

2.9

3.0

1.91

1.30

e6/l

2.44

571

6134

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2411

16862

1.29

22.38

2.3

2.4

3.35

3.24

mg/l

1.39

1863

14165

(4034850) Laboratory test

328

1537

1.83

22.36

10.0

13.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

332

4799

0.57

22.31

2.2

2.4

45.70

36.62

u/l

0.23

259

4042

(3002030) Lymphocytes/100 leukocytes in Blood

2391

24012

0.78

22.14

4.7

5.8

23.73

24.57

2.62

2090

21995

(40761536) Microorganisms panel - Urine sediment

770

4491

1.49

22.11

5.1

4.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1121

12466

0.72

21.50

4.4

138.91

488.45

ng/l

4.64

982

11238

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2397

16846

1.28

21.16

2.3

2.5

58.85

61.60

u/l

1.10

2118

15374

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

477

6215

0.63

21.04

1.2

10.96

15.97

u/ml

0.94

171

2005

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

589

7254

0.66

19.88

2.6

3.7

27.26

26.71

ug/l

0.02

459

6095

(3021589) Normoblasts [#/volume] in Blood

2133

21472

0.79

19.43

11.9

10.8

0.00

e9/l

1.18

1820

17314

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

212

3.17

19.04

1.6

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

212

3.17

19.04

1.6

2.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

120

3.96

18.80

1.4

1.2

34.20

67.35

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

250

2.96

18.70

1.2

2.03

2.28

mmol/l

1.79

224

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

537

6642

0.66

18.44

1.2

1.3

47.11

41.98

iu/ml

0.24

136

2009

(3044242) Glucose [Moles/volume] in Arterial blood

108

353

2.60

18.28

1.5

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1354

14304

0.76

17.77

2.5

3.0

4898.95

7407.18

umol/l

1.18

1008

11932

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

134

2364

0.47

17.05

1.8

2.9

695.41

3626.21

u/ml

1.54

101

1987

(3037522) Nuclear Ab [Titer] in Serum

399

5143

0.64

16.63

1.2

1.3

481.90

517.32

titre

0.15

1211

(3001604) Monocytes [#/volume] in Blood

2538

24746

0.81

16.60

4.0

5.2

0.63

0.65

e9/l

1.96

2153

20733

(3006315) Basophils [#/volume] in Blood

2553

24861

0.81

16.45

4.0

5.2

0.04

e9/l

2.01

2159

20854

(3011397) Hemoglobin [Presence] in Urine by Test strip

1748

12140

1.27

16.28

5.6

4.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

414

2262

1.57

16.02

1.6

1.5

1.63

1.68

0.44

324

1789

(3007164) IgA [Mass/volume] in Serum or Plasma

604

7121

0.69

15.99

1.6

1.5

2.92

2.78

g/l

0.46

329

3831

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1150

7584

1.32

15.85

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

475

5843

0.67

15.77

2.3

2.5

11.96

10.43

umol/l

0.46

348

5067

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

495

2824

1.51

15.75

2.0

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

199

3013

0.55

15.73

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

462

2605

1.53

15.54

2.0

1.8

—

(40758558) Short blood count panel - Blood

1204

12707

0.77

15.37

4.4

6.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1150

7636

1.31

15.05

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

254

3535

0.59

14.68

1.3

—

(3013115) Eosinophils [#/volume] in Blood

2661

25578

0.82

14.46

4.1

5.4

0.20

e9/l

0.12

2208

21714

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

324

2.47

14.37

1.4

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

109

1932

0.47

14.10

1.5

2.3

0.00

g/l

-0.00

1759

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

508

2991

1.46

13.84

1.6

1.8

3.06

2.47

ug/l

0.39

367

2552

(3016018) Differential panel - Cerebral spinal fluid

281

2.54

13.68

1.3

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

731

8119

0.74

13.29

2.8

3.5

245.51

251.19

u/l

0.46

604

7543

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

116

1964

0.49

13.17

1.5

2.3

0.00

g/l

0.73

1765

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4718

42856

0.84

12.83

4.1

4.8

1.45

1.44

mmol/l

0.60

3766

37505

(3019198) Lymphocytes [#/volume] in Blood

2651

25282

0.83

12.72

4.1

5.3

1.71

1.87

e9/l

3.06

2264

21680

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

609

6900

0.73

12.57

3.6

3.3

242.56

304.66

ng/l

3.05

553

6338

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

267

3536

0.63

12.54

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

156

699

1.90

12.40

1.0

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

131

2089

0.52

12.36

1.5

2.3

0.01

0.05

g/l

2.27

103

1882

(3003694) ABO and Rh group [Type] in Blood

1040

10893

0.78

12.18

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4795

43399

0.85

12.05

4.1

4.8

4.26

4.29

mmol/l

1.03

3863

38354

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1260

0.40

11.80

2.0

2.1

3.58

3.65

g/l

0.13

1178

(40768797) Stomach Pathology biopsy report

617

6908

0.74

11.76

1.2

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

531

6076

0.72

11.64

4.0

5.8

12.18

12.72

mmol/l

0.75

458

5641

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

366

2097

1.49

11.47

1.8

2.2

877.16

535.73

ug/l

0.84

333

1992

(3010421) pH of Blood

315

1751

1.54

11.38

3.6

4.5

7.42

0.96

283

1585

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5031

39638

1.17

11.18

5.3

7.5

82.41

84.53

u/l

1.22

4385

36859

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

255

3319

0.64

11.09

6.0

7.8

—

(3019225) pH of Specimen

922

6182

1.29

11.06

4.3

4.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

207

2806

0.61

10.78

2.1

2.5

0.36

0.34

u/ml

0.46

116

1630

(3002385) Erythrocyte distribution width [Ratio]

4183

38098

0.86

10.70

22.1

23.1

15.34

15.68

3.59

4017

37216

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

218

2911

0.62

10.64

1.5

2.2

3.64

3.67

g/l

0.09

154

2556

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

2769

0.62

10.52

1.5

2.2

10.26

10.51

g/l

0.30

136

2384

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4588

41468

0.86

10.50

3.6

4.3

1.22

1.23

mmol/l

0.32

3603

35831

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

838

0.32

10.40

1.6

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1115

11389

0.80

10.36

2.8

3.5

0.92

0.91

ug/l

0.05

748

8415

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

221

2920

0.63

10.31

1.5

2.2

7.44

7.59

g/l

0.56

155

2564

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

221

2917

0.63

10.26

1.5

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

293

3643

0.67

10.24

1.4

1.5

—

(3019060) Gas panel - Arterial blood

709

4637

1.32

10.23

3.3

4.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

143

2089

0.57

10.03

2.3

4.0

242.90

92.99

u/ml

1.25

131

1983

(3000850) Epithelial cells [#/volume] in Urine

1797

13093

1.20

10.01

3.0

2.8

6.22

4.98

e6/l

3.34

1663

11674

(3036489) Thrombin time

101

1629

0.52

9.96

1.7

20.70

22.07

1.11

1483

(3013707) Erythrocyte sedimentation rate by Westergren method

4611

36256

1.16

9.92

3.8

4.4

16.38

16.59

mm/h

0.34

3881

32679

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5022

44993

0.86

9.85

4.5

5.5

2.40

2.44

mmol/l

1.73

4050

39592

(3012501) Base excess in Blood by calculation

276

1541

1.53

9.82

3.8

4.6

2.64

2.95

mmol/l

0.88

184

1045

(3013290) Carbon dioxide [Partial pressure] in Blood

276

1543

1.53

9.77

3.8

4.6

5.01

5.03

kpa

0.15

264

1493

(3022145) Colonoscopy Study observation

455

5185

0.73

9.69

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1332

13271

0.82

9.67

2.2

2.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1438

0.50

9.51

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1412

13964

0.83

9.47

2.6

3.0

33.45

36.98

u/l

1.63

1265

13006

(3027315) Oxygen [Partial pressure] in Blood

275

1547

1.52

9.47

3.8

4.6

7.88

8.18

kpa

2.56

262

1497

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

102

1613

0.53

9.46

1.6

1.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

4.15

9.44

1.0

1.1

15.67

53.35

—

(3019977) pH of Arterial blood

103

442

1.98

9.40

1.7

2.2

7.43

7.42

0.33

177

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

275

2.25

9.31

1.1

—

2.65

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

244

3083

0.66

9.26

2.5

3.7

24.02

24.06

mmol/l

0.07

227

2968

(4200892) Spirometry reversibility

293

3567

0.68

9.19

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2961

22624

1.16

9.13

3.3

3.4

2070.88

2284.00

ng/l

1.53

2376

19781

(40760892) CBC W Ordered Manual Differential panel - Blood

2473

23221

0.86

8.88

4.8

5.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3133

28909

0.87

8.86

5.3

8.1

4.86

4.51

e9/l

8.45

2690

24720

(40768443) Skin Pathology biopsy report

196

2568

0.64

8.84

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

1104

0.46

8.76

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

207

2657

0.65

8.50

1.5

2.3

2.82

3.06

g/l

2.27

141

2300

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

529

0.24

8.41

1.3

1.5

—

(21494755) Public health laboratory ask at order entry panel

307

0.16

8.27

1.2

1.5

—

(36660697) Celiac disease serology panel - Serum

221

2773

0.66

8.14

1.2

—

(3000494) Fungus identified in Specimen by Culture

483

5311

0.75

8.08

1.3

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

510

3300

1.32

7.97

3.3

4.4

44.27

46.25

1.13

504

3262

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

914

9290

0.81

7.96

2.2

2.6

19.88

20.53

0.68

628

7833

(3028026) IgM [Mass/volume] in Serum or Plasma

208

2626

0.66

7.90

2.0

1.9

1.75

1.52

g/l

0.29

154

2310

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

187

2410

0.65

7.85

1.6

2.4

1.76

1.32

g/l

0.41

123

1994

(3021879) Hepatitis B virus core Ab [Presence] in Serum

138

1902

0.61

7.80

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

147

1995

0.62

7.78

3.3

3.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.32

7.76

2.3

2.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

172

2239

0.64

7.58

1.4

2.2

36.70

36.58

g/l

0.07

103

1875

(3003458) Phosphate [Moles/volume] in Serum or Plasma

822

8385

0.81

7.39

3.4

5.0

1.03

1.05

mmol/l

1.31

670

7583

(3017143) Hepatitis C virus Ab [Presence] in Serum

253

3027

0.70

7.26

1.3

1.4

—

(3000991) Gas panel - Venous blood

508

5467

0.77

7.24

3.7

6.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

144

2.53

7.18

3.3

2.8

25.57

29.73

umol/l

1.73

112

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

265

3134

0.70

7.12

1.3

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.20

7.12

2.3

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2606

24094

0.88

7.09

2.5

2.8

—

(3030467) Casts [#/volume] in Urine by Automated count

1766

16775

0.86

7.06

3.3

3.5

0.64

0.55

e6/l

1.01

1479

13133

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

214

2.22

7.01

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.91

6.97

1.3

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

327

3714

0.73

6.86

1.6

1.7

1.60

1.55

g/l

0.43

230

3147

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

787

0.44

6.80

3.1

3.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

702

4829

1.25

6.79

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

810

0.45

6.79

1.4

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

986

9770

0.83

6.54

2.1

2.5

2.18

2.23

g/l

1.64

772

8887

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

138

1811

0.64

6.38

1.5

1.6

37.69

38.28

u/l

0.11

103

1501

(3023183) Ammonium ion [Moles/volume] in Plasma

171

953

1.53

6.30

1.6

2.0

27.02

33.30

umol/l

2.61

142

823

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

3.83

6.27

1.6

2.9

141.57

144.83

nmol/l

0.04

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

996

0.52

6.20

1.2

3.15

5.77

u/ml

—

164

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

146

1876

0.65

6.13

1.7

1.5

97.14

280.73

titre

2.25

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1047

0.54

6.13

1.2

3.83

38.54

u/ml

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

381

0.24

6.10

1.1

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

381

0.24

6.10

1.1

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

967

0.52

6.07

1.1

80.00

90.85

titre

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

195

2.17

6.01

1.1

1.2

0.88

0.97

promille

0.16

144

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

984

0.53

5.98

1.2

2.15

8.40

u/ml

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1136

0.56

5.97

1.5

1.7

11.88

12.67

mg/l

0.29

1022

(1002224) Polysomnography panel

600

0.41

5.86

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

575

3937

1.25

5.83

1.6

2.1

389.41

383.49

nmol/l

0.28

466

3534

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

885

0.51

5.79

1.2

—

0.73

—

(3025941) Bacteria identified in Stool by Culture

380

2480

1.31

5.67

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

987

0.54

5.63

1.1

—

1096.54

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

284

0.27

5.63

1.1

96.89

90.53

—

255

(3006270) Folate [Moles/volume] in Blood

108

556

1.65

5.60

1.3

1.2

305.27

310.54

nmol/l

0.08

402

(40768793) Breast Pathology biopsy report

983

0.55

5.56

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

964

9434

0.85

5.51

2.2

2.6

0.82

mmol/l

0.21

806

8600

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

607

0.43

5.50

1.4

1.5

4.23

2.99

mg/l

0.37

478

(40767503) Oxygen content in Capillary blood by calculation

243

1490

1.39

5.49

2.5

2.7

15.86

15.54

0.53

104

815

(3036603) Volume of Urine

355

0.26

5.46

2.9

1.5

1361.27

1732.69

1.09

334

(3032057) Clostridioides difficile [Presence] in Stool

171

2.18

5.38

1.6

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4870

42980

0.90

5.28

19.1

19.2

65.96

ml/min/173m2

0.00

3744

35995

(40768795) Lymph node Pathology biopsy report

488

0.38

5.27

1.0

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

292

3238

0.75

5.27

3.0

2.6

11.14

10.88

g/l

0.28

239

2907

(3017446) Testosterone [Moles/volume] in Serum or Plasma

217

2516

0.72

5.27

1.6

2.0

9.12

9.91

nmol/l

0.74

172

2074

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

739

0.50

5.13

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5922

48253

1.12

5.06

8.9

11.6

21.71

22.99

u/l

1.78

5317

45714

(3012441) Differential panel - Pleural fluid

1007

0.58

5.03

1.4

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

139

2.25

4.93

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

522

3606

1.24

4.92

2.7

3.5

25.29

25.02

mmol/l

1.07

509

3502

(3003434) Protein [Mass/volume] in Pleural fluid

101

1333

0.64

4.89

1.3

1.5

29.68

30.54

g/l

0.31

1176

(3048689) Calprotectin [Mass/mass] in Stool

399

4195

0.79

4.76

1.6

1.8

180.26

171.78

ug/g

0.17

258

3181

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

606

0.47

4.75

1.4

1.2

—

21.21

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1169

0.62

4.75

1.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.93

4.75

1.1

1.2

55.67

42.92

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

345

3688

0.78

4.73

2.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

253

1603

1.34

4.71

2.2

2.3

125.05

124.81

g/l

0.05

225

1179

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

153

2.16

4.70

1.1

36.28

47.67

mg/l

1.30

127

(36304419) Bacteria [Presence] in Urine

1709

15889

0.89

4.70

3.3

3.5

—

(3014051) Protein [Presence] in Urine by Test strip

117

1483

0.66

4.69

3.8

3.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

220

2496

0.74

4.68

2.8

2.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

568

0.46

4.68

1.1

1.5

0.67

0.87

g/l

0.35

419

(40768806) Pleura Pathology biopsy report

1007

0.59

4.67

1.4

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

423

0.38

4.64

1.8

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

384

0.35

4.60

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

327

3502

0.78

4.57

4.9

4.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3206

25410

1.10

4.53

2.9

3.1

50.97

59.33

u/l

4.92

2673

22556

(3023199) Leukocytes [#/volume] in Pleural fluid

1162

0.63

4.48

1.3

1.5

1433.90

1849.22

e6/l

0.58

850

(40768441) Liver Pathology biopsy report

300

0.28

4.44

1.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

643

0.51

4.36

1.2

—

(40768800) Prostate Pathology biopsy report

101

1297

0.65

4.35

1.1

1.2

—

(3005570) Glucose [Moles/volume] in Urine

120

676

1.51

4.34

2.6

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

708

0.53

4.34

3.4

3.2

—

(3025130) Human papilloma virus identified in Specimen

189

0.22

4.28

2.0

1.6

—

(3011985) Renin [Units/volume] in Plasma

582

0.49

4.27

1.2

1.3

85.60

46.84

mu/l

0.44

505

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

105

2.34

4.24

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

405

0.39

4.23

1.2

3.83

4.37

u/ml

—

188

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1197

0.65

4.23

1.2

—

(1616796) Gas panel - Central venous blood

249

1603

1.32

4.20

3.3

3.9

—

(3045788) Cell count panel - Pleural fluid

883

0.59

4.19

1.3

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

144

2.12

4.17

1.0

268.11

324.28

mg/l

1.09

124

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

784

0.57

4.14

4.9

3.6

124.88

4140.76

iu/ml

—

108

(3028308) Erythrocytes [#/volume] in Pleural fluid

1065

0.63

4.09

1.3

1.5

83162.96

55740.85

e6/l

0.33

632

(3044640) Blood type and Crossmatch panel - Blood

1923

17633

0.90

4.08

2.3

2.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

627

0.52

4.06

1.1

—

(3008898) HLA-B27 [Presence]

582

0.51

4.05

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

346

0.36

4.01

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

523

0.48

4.00

1.5

1.2

127.44

119.63

u/ml

—

112

(3036782) Glucose [Moles/volume] in Pleural fluid

839

0.59

3.98

1.2

1.4

6.35

6.50

mmol/l

0.20

786

(3008116) Ketones [Moles/volume] in Urine by Test strip

103

2.30

3.97

1.1

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

531

0.49

3.93

1.1

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

501

1.56

3.92

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

351

0.38

3.84

1.1

1.2

—

110.00

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

614

0.53

3.82

1.4

1.2

—

(3044889) 12 lead EKG panel

3898

34475

0.92

3.79

4.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

493

1.55

3.75

1.3

—

(3008295) Osmolality of Serum or Plasma

555

1.51

3.72

1.2

1.3

273.82

274.22

mosm/kgh2o

0.05

392

(3022948) Iron [Moles/volume] in Serum or Plasma

1113

10482

0.88

3.72

2.1

2.6

10.74

11.35

umol/l

2.01

872

9588

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1142

0.66

3.72

1.3

1.4

0.23

g/l

0.02

1066

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1172

0.67

3.71

1.3

1.4

1.19

1.15

g/l

0.72

1095

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

146

2.03

3.68

1.2

1.4

125.42

75.99

umol/l

0.65

(3024928) Oxygen saturation in Venous blood

102

1260

0.68

3.68

1.5

2.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

324

1.67

3.68

1.5

2.1

19.46

21.84

umol/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

129

2.10

3.67

2.3

2.1

61.19

46.60

umol/l

1.37

103

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

268

0.31

3.66

1.6

2.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.36

3.62

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.59

3.60

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

1042

0.65

3.59

1.5

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

131

2.07

3.54

1.3

1.5

18.08

16.63

pmol/l

0.62

(3042936) Bacteria identified in Isolate by Culture

857

8176

0.87

3.49

1.8

2.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1005

9481

0.88

3.45

1.6

1.9

29.92

30.42

1.36

949

9186

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

538

0.53

3.42

1.1

1.3

236.34

250.75

pmol/l

0.17

448

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

180

1.88

3.42

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.25

3.41

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.25

3.41

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

844

0.63

3.39

1.3

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

293

0.37

3.36

1.3

2.0

—

(3045414) Leukocytes [Presence] in Urine

205

2232

0.77

3.36

2.4

2.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.54

3.34

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

367

1.59

3.31

2.6

2.0

2.08

2.56

u/field

0.27

238

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

841

8000

0.88

3.28

1.2

1.51

1.64

u/ml

0.14

272

1859

(3047189) Immunofixation for 24 hour Urine

334

0.43

3.20

1.0

1.4

—

(3011288) Drugs identified in Urine by Screen method

2.82

3.20

1.5

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

580

0.57

3.20

1.6

1.3

—

(3016502) Oxygen saturation in Arterial blood

906

6818

1.14

3.17

3.7

6.0

95.24

95.05

0.45

868

6524

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.21

3.15

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.21

3.15

3.2

2.7

0.25

0.39

u/field

0.62

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

129

1483

0.73

3.12

1.1

0.99

1.04

u/ml

—

(40757373) Influenza virus identified in Isolate

138

1.96

3.12

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

138

1.96

3.12

1.1

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

244

0.35

3.09

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

244

0.35

3.09

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

243

0.35

3.07

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

243

0.35

3.07

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

243

0.35

3.07

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

243

0.35

3.07

1.3

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

101

1203

0.71

3.05

1.7

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

516

0.55

3.02

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.16

3.01

1.0

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

890

0.66

3.00

1.3

297.56

350.80

u/l

0.40

846

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

151

0.28

2.99

1.0

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1168

0.71

2.98

1.5

0.55

9.44

iu/ml

1.24

326

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

140

877

1.35

2.95

1.9

2.2

34.32

29.37

mg/l

0.39

196

(3027945) Reticulocytes/100 erythrocytes in Blood

1130

8658

1.12

2.95

2.3

2.2

1.75

1.76

0.17

846

7513

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

521

0.57

2.91

1.1

—

(4281824) Cell count and differential, peritoneal fluid

542

0.57

2.90

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

699

0.63

2.89

3.9

3.5

52.00

58.07

0.67

570

(3027456) Digoxin [Moles/volume] in Serum or Plasma

319

2225

1.22

2.88

3.6

3.2

0.82

nmol/l

0.01

230

1704

(3039443) Prostate specific Ag panel - Serum or Plasma

384

0.50

2.81

1.6

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

555

0.59

2.76

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

338

3400

0.83

2.74

1.3

1.4

—

(3011648) Oxygen content in Venous blood

380

0.51

2.73

1.1

1.4

10.54

10.29

0.10

380

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

357

0.50

2.72

1.2

—

(3022621) pH of Urine by Test strip

510

3731

1.16

2.71

3.7

3.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

189

1.75

2.70

1.3

1.4

79.18

63.24

4.26

164

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

146

1.85

2.69

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

549

0.60

2.66

1.1

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1179

10858

0.90

2.65

1.5

1.6

1.95

1.67

mg/l

0.91

888

8511

(3006653) Thiamine [Moles/volume] in Blood

178

1.76

2.64

1.1

120.30

134.59

nmol/l

1.16

178

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

375

0.52

2.63

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

191

1274

1.27

2.61

1.3

62.76

60.11

mmol/l

0.44

149

1018

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

258

0.42

2.58

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

131

832

1.33

2.57

1.3

1.4

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.68

2.57

1.0

1.2

23.39

11.82

pmol/l

0.75

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

480

0.58

2.57

1.1

342.19

305.07

u/ml

0.29

275

(3035637) Corticotropin [Mass/volume] in Plasma

480

0.58

2.57

1.0

1.4

—

(3013512) EKG study

2215

17629

1.08

2.57

4.7

4.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

153

0.33

2.56

1.2

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

280

0.45

2.55

3.6

1.7

66.33

70.12

0.54

259

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

244

0.41

2.53

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

562

1.40

2.50

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1080

0.72

2.48

1.5

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

129

1427

0.76

2.48

1.2

0.33

0.92

u/ml

1.46

147

(3032773) Endomysium IgG Ab [Titer] in Serum

293

1.56

2.47

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

671

0.65

2.46

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

557

1.40

2.45

1.3

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

382

1.48

2.45

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

121

1347

0.75

2.44

1.5

2.7

182.02

871.00

u/ml

1.99

101

1229

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

191

0.40

2.43

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

286

0.47

2.43

1.1

1.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

429

4182

0.86

2.43

3.1

3.5

0.57

0.68

0.35

120

1507

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

274

0.46

2.42

3.7

1.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

151

0.34

2.41

2.3

1.6

48.17

123.40

ug/l

—

128

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

103

1170

0.74

2.39

1.4

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

213

0.40

2.37

1.5

1.1

0.08

0.84

u/ml

—

102

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.17

2.34

1.2

1.1

1751.83

1612.14

miu/ml

0.16

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

102

634

1.36

2.34

1.6

31.32

26.99

u/ml

0.39

138

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

270

0.47

2.33

3.5

1.7

24.67

17.67

1.09

259

(3023419) Bacteria identified in Sputum by Culture

1008

0.73

2.31

1.7

2.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

644

6083

0.89

2.30

2.0

2.4

65.23

65.80

g/l

0.91

502

5369

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

690

0.67

2.29

1.3

20.37

11.79

u/l

0.57

637

(3017181) Myelocytes/100 leukocytes in Blood

483

4646

0.87

2.29

3.3

3.6

1.15

0.94

0.44

162

1772

(3021440) Promyelocytes/100 leukocytes in Blood

459

4429

0.87

2.28

3.3

3.7

0.13

0.10

0.37

141

1566

(3028707) Methadone [Presence] in Urine by Screen method

2.50

2.27

1.5

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

359

3526

0.85

2.26

4.5

5.8

24.55

24.81

mmol/l

0.62

348

3478

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

1.71

2.25

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

175

1837

0.80

2.23

1.2

284.41

241.08

u/ml

0.35

150

1661

(3003888) Timothy IgE Ab [Units/volume] in Serum

179

0.42

2.21

1.0

—

1.18

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

417

0.59

2.21

1.3

16.58

12.59

u/l

0.68

321

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

102

641

1.35

2.20

2.6

3.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

872

0.71

2.20

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

536

4004

1.14

2.18

3.9

7.1

0.77

0.67

8.50

530

3970

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

558

0.65

2.13

1.5

1.3

—

nmol/l

—

(3038026) Centromere Ab [Units/volume] in Serum

402

0.59

2.13

1.1

1.2

—

79.21

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

557

0.65

2.12

1.0

1.2

59.11

59.78

u/l

0.03

501

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

178

1.66

2.11

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

340

1.47

2.09

1.2

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

340

1.47

2.09

1.2

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

893

0.73

2.09

1.1

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

176

0.43

2.09

1.0

—

1.52

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

672

5107

1.12

2.08

1.6

2.0

0.19

g/l

0.95

560

4655

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

723

0.70

2.05

1.1

—

(3016038) Potassium [Moles/volume] in Urine

441

1.40

2.03

1.1

30.86

34.85

mmol/l

1.03

361

(1617658) Protocol used for examination of sentinel lymph nodes

352

0.57

2.00

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

221

1552

1.21

1.97

1.9

2.2

92.96

89.87

ug/min

0.04

876

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.00

1.94

1.2

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

1.90

0.0

1.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

121

0.35

1.89

2.2

1.8

25.80

30.51

—

110

(3006245) CD3-CD19+ cells/100 cells in Blood

122

0.35

1.88

2.4

1.8

8.20

10.31

—

108

(3051651) Icteric interference index of Serum or Plasma

377

0.60

1.88

3.2

3.4

—

(3000012) Reticulocyte production index

173

1193

1.23

1.87

2.0

2.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

546

4131

1.12

1.85

2.6

3.3

127.17

124.70

g/l

1.99

535

4024

(21494434) Karyotype in Bone marrow

577

0.69

1.82

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

382

0.62

1.79

2.8

2.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

484

0.66

1.78

1.1

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

130

0.39

1.78

1.2

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

751

0.73

1.78

1.6

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

166

0.46

1.73

1.0

1.4

64.91

32.30

iu/l

—

142

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

159

1633

0.82

1.73

1.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

529

1.33

1.71

1.2

1.4

191.54

341.89

titre

0.44

(3001019) Free T4 and TSH panel - Serum or Plasma

345

0.61

1.69

1.3

1.6

—

(3035880) pH of Pleural fluid

518

0.68

1.69

1.2

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

542

4126

1.12

1.68

3.1

3.8

1.85

2.10

mmol/l

0.78

386

3036

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

457

0.66

1.68

1.4

1.7

4.52

5.07

mg/l

0.37

429

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

565

4324

1.11

1.60

3.1

3.9

5.16

5.17

kpa

0.07

497

4051

(3009343) pH of Capillary blood

558

4270

1.11

1.59

3.1

3.9

7.43

7.42

1.44

561

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

194

1380

1.19

1.58

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

1.54

0.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

122

0.41

1.53

1.3

1.5

0.96

0.87

g/l

—

122

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

1.52

0.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

1.52

0.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

196

0.52

1.50

1.9

2.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

554

0.71

1.50

2.0

3.6

33.28

45.59

u/ml

0.76

536

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

358

1.37

1.50

1.2

1.19

1.48

nmol/l

1.57

320

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.97

1.49

1.4

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5056

43560

0.95

1.49

6.7

7.0

43.07

41.58

mmol/mol

15.00

4106

38775

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

414

0.67

1.48

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

206

0.53

1.48

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

106

714

1.26

1.48

1.5

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

432

0.68

1.45

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

103

694

1.26

1.44

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

131

0.45

1.44

6.7

3.0

—

72.42

—

(3000764) Benzodiazepines [Presence] in Urine

1.89

1.43

1.4

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

500

0.71

1.43

1.3

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

538

4979

0.91

1.42

2.6

3.6

89.73

103.12

ng/l

2.48

357

4107

(3014765) Yersinia sp identified in Stool by Organism specific culture

194

1396

1.18

1.41

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

194

1397

1.18

1.40

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

191

0.53

1.40

2.9

2.0

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.46

1.40

1.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

825

6479

1.08

1.38

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

1.36

0.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

504

0.72

1.35

1.1

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

513

1.29

1.34

1.2

1.4

51.43

51.50

titre

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

268

2571

0.88

1.34

2.5

2.9

47.03

91.01

mg/l

1.28

196

2109

(3002173) Hemoglobin [Mass/volume] in Arterial blood

773

6063

1.08

1.34

3.9

6.4

119.67

118.19

g/l

1.27

756

5894

(3000475) Leukocytes [#/volume] in Synovial fluid

137

1385

0.83

1.33

1.7

1.6

27517.37

14562.90

e6/l

0.95

107

991

(3027944) Amphetamines [Presence] in Urine

1.84

1.33

1.4

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.00

1.33

0.0

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

1.33

0.0

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

258

1909

1.15

1.32

2.7

3.3

24.84

25.05

mmol/l

0.35

253

1870

(3025159) Blasts/100 leukocytes in Blood

440

4096

0.90

1.32

3.3

3.6

0.14

0.41

1.16

119

1263

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

187

0.54

1.32

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

187

0.54

1.32

1.3

1.9

725.00

20485.55

e6/l

—

110

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

187

0.54

1.32

1.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

686

5358

1.09

1.32

2.5

3.1

4.01

4.35

kpa

6.14

654

5134

(3028717) Thiamine [Mass/volume] in Blood

2.41

1.30

1.0

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

103

1068

0.81

1.30

1.2

1.3

29.83

42.37

u/l

1.36

902

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

268

2565

0.88

1.30

2.5

2.9

40.49

58.46

mg/l

0.98

198

2104

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

490

0.72

1.30

1.1

—

u/ml

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

155

1.53

1.29

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

321

0.66

1.29

1.2

1.5

6.35

7.15

u/l

0.13

258

(3027008) Opiates [Presence] in Urine

1.81

1.28

1.4

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.11

1.27

1.0

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

135

0.50

1.25

1.3

1.4

26.75

29.36

umol/l

—

129

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

261

2494

0.88

1.25

2.5

2.9

3.72

2.93

ratio

0.28

181

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

553

0.75

1.24

1.2

—

(40765096) Chromosome analysis panel by Banding

161

0.52

1.23

1.2

1.1

—

(3016228) CD19 cells/100 cells in Blood

161

0.52

1.23

4.1

1.6

4.60

8.34

—

151

(3028300) Cannabinoids [Presence] in Urine

1.79

1.23

1.4

1.1

—

(4062490) Immunoglobulin typing, IgG

345

0.68

1.20

1.2

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

202

0.58

1.20

1.4

2.0

423.33

3718.81

e6/l

—

146

(3036180) Methadone [Presence] in Urine

2.64

1.19

1.4

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

552

4293

1.09

1.19

1.9

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

243

0.62

1.18

1.0

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

243

0.62

1.18

1.0

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

344

0.69

1.18

1.1

1.3

6.20

7.14

g/l

0.55

244

(3028192) IgG subclass 2 [Mass/volume] in Serum

344

0.69

1.18

1.1

1.2

2.78

2.86

g/l

0.08

247

(3024139) IgG subclass 3 [Mass/volume] in Serum

344

0.69

1.18

1.1

1.3

0.43

0.50

g/l

0.36

246

(21491868) Cryoglobulin [Mass/volume] in Serum

158

0.53

1.17

1.1

1.2

—

0.29

g/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

1.17

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

1.17

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

1.17

0.0

1.1

—

(3001729) Color of Synovial fluid

1.79

1.17

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

313

0.67

1.17

1.1

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.1

—

0.36

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3468

28539

1.04

1.16

3.8

5.8

12.33

12.86

umol/l

1.14

3056

26961

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

663

1.22

1.14

2.6

2.3

2.61

2.15

u/field

0.41

213

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.48

1.12

1.6

20.28

15.48

umol/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

349

0.70

1.11

1.1

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

625

5672

0.92

1.11

3.2

5.3

1.54

1.42

mmol/l

2.06

593

5447

(3004809) Band form neutrophils/100 leukocytes in Blood

114

1147

0.84

1.10

4.5

3.6

1.52

1.54

0.02

983

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

742

6688

0.93

1.10

4.1

4.9

34.79

34.28

0.46

344

4252

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

140

1006

1.18

1.10

2.6

3.3

61.71

59.88

0.78

140

1006

(3002619) Bacteria identified in Specimen by Culture

119

0.50

1.10

1.4

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

758

0.80

1.09

1.6

4.18

4.29

mmol/24h

0.10

621

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

841

0.81

1.08

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

841

0.81

1.08

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

191

1842

0.87

1.08

1.1

70.89

123.02

iu/ml

2.06

592

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

386

0.72

1.08

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

185

0.59

1.07

1.8

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

246

2332

0.89

1.07

2.3

2.5

25.36

23.53

au/ml

—

(3018095) Leukocytes [#/volume] in Urine

2500

20466

1.04

1.05

4.1

234.48

141.57

e6/l

1.70

1959

15163

(3000570) Elastase.pancreatic [Mass/mass] in Stool

163

1584

0.87

1.04

1.3

1.4

245.16

259.73

ug/g

0.44

999

(3016879) Cocaine [Presence] in Urine

1.71

1.03

1.4

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

151

0.56

1.03

4.1

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

526

0.77

1.03

2.3

3.1

46.06

35.13

mg/l

0.26

395

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.85

0.99

1.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

311

0.70

0.99

1.1

1.4

—

(40758358) Immune stain study

0.00

0.97

0.0

1.0

—

(3044941) Cell count panel - Synovial fluid

901

0.83

0.96

1.6

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

100

0.51

0.95

1.7

1.3

53.67

250.76

nmol/24h

—

100

(3004716) Salmonella sp identified in Stool by Organism specific culture

205

1538

1.13

0.93

1.3

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.84

0.92

1.3

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

374

0.74

0.92

1.3

1.5

53.76

68.64

1.15

301

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

247

0.68

0.92

1.2

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.48

0.90

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

185

0.64

0.89

1.4

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

177

1.38

0.89

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.88

0.87

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

273

1.30

0.87

1.0

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

173

0.63

0.86

1.1

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

471

0.79

0.83

1.1

108.39

635.40

iu/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.76

0.82

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

131

1.42

0.79

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

124

1.43

0.78

1.1

0.99

1.18

u/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.78

0.0

10.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

0.00

0.78

0.0

1.3

—

0.12

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

105

0.56

0.78

1.0

—

1.87

—

(40768446) Kidney Pathology biopsy report

106

0.56

0.78

1.0

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.81

0.78

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2460

20251

1.04

0.78

4.6

5.9

4.31

5.66

ug/l

1.38

1987

17585

(3017732) Neutrophils [#/volume] in Blood

394

3091

1.08

0.77

3.1

3.3

7.03

5.77

e9/l

0.42

220

2176

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

494

0.80

0.77

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

114

0.59

0.74

1.3

1.2

—

(3003396) Base excess in Arterial blood by calculation

955

7719

1.05

0.73

3.7

5.7

1.42

1.13

mmol/l

1.61

706

5993

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

225

0.71

0.73

1.0

268.67

295.32

mg/l

0.63

193

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.56

0.73

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.01

0.72

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

113

1090

0.87

0.72

2.4

2.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2511

20708

1.03

0.71

2.6

3.0

151.36

161.62

ug/l

0.95

2017

18384

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

144

0.64

0.70

1.2

1.6

15.53

257.13

ug/l

0.68

135

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

224

2072

0.91

0.70

1.2

1.3

44.11

59.75

au/ml

0.59

109

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

231

1.28

0.69

4.9

5.4

68.83

74.51

0.53

180

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.60

0.68

3.7

8.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.84

0.67

1.2

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.53

0.67

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.64

0.67

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.64

0.67

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.64

0.67

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

217

1.29

0.67

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.52

0.67

1.0

1.3

—

13.53

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.52

0.67

1.2

1.1

—

(3003338) MCHC [Mass/volume]

4206

35001

1.03

0.65

26.3

26.8

329.89

329.91

g/l

0.06

4033

34498

(3002079) Sodium [Moles/time] in 24 hour Urine

151

0.67

0.65

1.2

107.42

142.74

mmol/24h

1.51

151

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

510

0.83

0.65

1.1

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

510

0.83

0.65

1.1

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

510

0.83

0.65

1.1

1.3

—

(3016750) Collection duration of Urine

389

0.80

0.64

1.9

2.0

507.71

502.49

min

0.09

272

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

416

0.81

0.63

2.9

3.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

169

1574

0.90

0.63

1.4

—

(3015183) Erythrocyte sedimentation rate

0.58

0.62

1.0

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.58

0.62

2.3

1.5

8.88

9.96

ug/l

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

138

1.35

0.62

1.5

1.3

20.57

31.53

0.76

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

175

1.30

0.62

1.7

59.59

63.20

ug/l

0.10

168

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.60

0.0

1.1

—

18.03

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.60

0.0

2.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.48

0.60

4.4

5.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.3

—

282.05

—

(3045424) Erythrocytes [Presence] in Urine

821

0.87

0.59

1.6

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

137

0.68

0.58

3.8

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.56

0.57

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

502

0.84

0.57

1.1

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

801

6500

1.04

0.56

2.5

2.4

65.90

66.80

e9/l

0.30

629

4956

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

409

0.82

0.56

1.0

1.1

—

10.34

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

331

1.20

0.56

5.3

3.2

—

(3049717) Cytology report of Urine Cyto stain

337

3028

0.94

0.55

2.7

2.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

106

0.64

0.55

3.8

2.3

—

(3000285) Sodium [Moles/volume] in Blood

112

1.36

0.54

1.5

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

2215

18313

1.03

0.54

3.6

168.34

132.04

e6/l

0.28

1853

14339

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.60

0.52

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

355

2827

1.06

0.52

3.5

4.4

1.53

0.02

337

2675

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

704

0.87

0.52

1.5

79.06

63.39

4.42

447

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

523

0.85

0.51

1.1

1.4

—

(3022313) Gas panel - Capillary blood

380

3036

1.06

0.50

3.2

4.0

—

(3028433) Virus identified in Specimen by Culture

152

0.72

0.50

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

330

0.82

0.50

1.4

1.5

2.66

2.59

0.02

266

(3037756) Immunofixation for Serum or Plasma

210

1646

1.08

0.49

1.3

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

541

1.14

0.49

1.3

1.4

11.85

26.85

11.75

345

(3018572) Chloride [Moles/volume] in Blood

171

1330

1.09

0.48

4.3

6.0

105.01

104.68

mmol/l

0.45

157

1193

(3039000) Anion gap in Blood

171

1330

1.09

0.48

4.3

6.0

11.37

11.32

mmol/l

0.07

157

1193

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

312

2486

1.06

0.47

3.7

4.4

24.93

24.85

mmol/l

0.15

249

2236

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

281

0.81

0.47

1.4

1.3

902.40

168.21

ug/l

0.42

151

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.61

0.46

12.2

8.5

13.40

13.89

—

(3000093) Morphology [Interpretation] in Blood Narrative

685

0.89

0.44

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

350

2805

1.06

0.44

3.4

4.4

0.87

0.85

0.24

333

2649

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.44

0.43

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.44

0.43

1.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

797

0.90

0.42

4.6

5.6

13.44

12.66

mg/l

0.62

716

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

1987.86

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.41

0.0

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

6.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.51

0.41

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

383

1.15

0.40

1.3

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

383

1.15

0.40

1.3

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

234

1.19

0.40

1.4

1.2

0.93

1.15

nmol/l

0.64

175

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.46

0.40

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.37

0.40

1.2

1.9

1.69

1.28

ug/l

0.22

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

285

2280

1.06

0.40

2.7

3.0

4.26

4.24

pmol/l

0.08

230

1930

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

900

0.91

0.40

1.2

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.39

0.0

2.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

829

0.91

0.39

1.1

—

16.38

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

473

4158

0.96

0.39

2.5

3.0

57.31

54.84

ml/min/173m2

0.82

198

2010

(3012544) pH of Venous blood

772

6720

0.97

0.39

2.6

3.6

7.39

7.38

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

274

0.83

0.39

1.0

1.1

51.09

31.49

u/l

0.56

243

(3036525) Urea [Moles/time] in 24 hour Urine

1.41

0.38

2.2

3.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

986

0.92

0.38

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

144

0.76

0.38

4.2

5.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.33

0.38

1.0

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1943

16127

1.02

0.37

4.6

5.1

20.86

22.72

7.36

1032

9020

(3020874) Milk IgE Ab [Units/volume] in Serum

0.65

0.36

1.0

1.1

—

0.45

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

206

1843

0.94

0.35

2.0

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

584

5096

0.97

0.35

2.0

2.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

216

0.82

0.35

1.0

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

179

0.80

0.35

1.0

1.1

—

(3021901) Oxygen saturation in Capillary blood

186

1477

1.06

0.35

2.5

3.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

822

0.91

0.35

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

530

0.89

0.34

1.4

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

530

0.89

0.34

1.4

1.3

—

(3025577) Chromium [Mass/volume] in Blood

414

0.88

0.34

1.9

2.0

1.83

2.20

ug/l

0.39

344

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

132

0.77

0.34

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

113

0.75

0.34

4.0

2.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

216

1925

0.95

0.33

2.7

3.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

214

0.83

0.33

1.0

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

351

1.13

0.32

1.7

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

730

0.91

0.32

1.1

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

222

0.84

0.31

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.34

0.31

1.0

—

(44813793) Dust mix specific IgE antibody measurement

194

0.83

0.30

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.30

1.0

1.1

—

(3002032) Base excess in Venous blood by calculation

754

6531

0.97

0.30

2.6

3.6

2.17

1.91

mmol/l

1.29

624

5388

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

727

0.92

0.30

1.1

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

735

0.92

0.30

1.1

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

548

1.09

0.29

1.3

1.4

292847.46

172014.09

e6/l

0.38

383

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

132

1046

1.07

0.28

1.3

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

164

1.18

0.28

3.2

2.5

7.66

7.44

mmol/l

0.16

104

(3004775) Volume in Urine collected for unspecified duration

566

0.91

0.28

1.8

2.1

642.56

645.59

0.01

349

(4146454) Self-monitoring of blood glucose

687

1.08

0.28

2.5

2.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

110

1.23

0.27

1.1

—

19.57

—

(3044007) Cell count panel - Peritoneal fluid

155

0.82

0.27

1.4

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

757

6539

0.98

0.26

2.7

3.6

5.86

5.82

kpa

0.44

723

6298

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

729

0.93

0.26

1.1

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

111

1.22

0.26

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.25

0.25

1.1

—

(3006462) Nitrate [Presence] in Urine

297

0.88

0.25

5.5

4.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

126

1127

0.94

0.25

2.8

2.6

—

(3004451) EKG impression Narrative

383

1.10

0.25

1.2

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

727

0.93

0.25

1.1

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

104

1.22

0.24

1.1

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

150

1202

1.05

0.24

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

116

0.80

0.24

1.3

1.5

132.91

135.07

ng/l

0.03

116

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.17

0.24

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

125

0.81

0.24

1.8

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

173

1393

1.05

0.24

1.3

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

143

0.83

0.24

2.1

1.4

10.88

9.57

ug/l

0.18

126

(3036670) Protein [Mass/volume] in Synovial fluid

215

0.86

0.23

1.2

40.30

39.30

g/l

0.17

(3041354) Potassium [Moles/volume] in Venous blood

128

1141

0.95

0.23

2.8

2.6

4.15

4.14

mmol/l

0.08

128

1132

(3035285) Chloride [Moles/volume] in Venous blood

128

1141

0.95

0.23

2.8

2.6

106.75

105.40

mmol/l

1.57

128

1131

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

202

1779

0.96

0.23

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

458

1.09

0.23

1.2

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.26

0.22

1.5

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

294

0.89

0.22

1.9

1.8

84.45

108.41

umol/l

2.62

294

(3014891) Appearance of Pleural fluid

160

0.84

0.22

1.5

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

749

0.93

0.22

2.1

2.2

1.09

1.04

g/24h

0.05

354

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.22

0.21

1.1

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

0.20

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

114

0.81

0.21

1.2

1.4

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

2.55

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

4.18

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

101

806

1.06

0.20

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

745

0.94

0.20

1.1

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

103

0.82

0.18

1.0

1.2

41.00

81.76

u/l

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.18

0.18

1.6

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

728

1.06

0.18

5.8

3.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

132

1.15

0.18

1.4

1.6

0.55

0.40

ug/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

140

1.15

0.18

1.6

2.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.73

0.17

1.8

1.2

—

1066.34

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.72

0.17

1.0

2.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.72

0.17

1.4

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.19

0.16

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

101

1.17

0.16

1.4

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

117

1.15

0.16

1.1

1.2

—

(1761868) Lipid panel - Serum or Plasma

1259

10751

0.99

0.16

3.5

3.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

138

1210

0.96

0.15

1.2

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

154

0.88

0.15

1.0

1.2

1.69

1.43

mmol/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

147

1286

0.96

0.15

2.4

2.5

1.87

1.92

mg/l

0.24

115

1113

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

103

833

1.04

0.14

1.2

1.4

—

(3037121) Protein [Mass/volume] in Urine

263

2165

1.03

0.14

2.4

2.7

0.36

0.31

g/l

0.29

830

(3020491) Glucose [Moles/volume] in Blood

388

0.94

0.13

1.8

2.6

7.70

7.26

mmol/l

0.55

258

(3024869) Neuronal Ab [Presence] in Serum

111

1.14

0.13

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.18

0.13

1.5

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

201

1.09

0.12

1.0

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

291

0.93

0.12

1.3

3.39

3.47

mmol/l

0.06

265

(3012565) Volume of 24 hour Urine

243

1.08

0.11

1.7

2.3

1444.50

1822.00

0.99

201

(3017569) Oxygen content in Arterial blood

367

1.06

0.11

2.0

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

260

1.07

0.11

1.2

1.3

—

(3033799) Differential panel - Peritoneal fluid

184

0.92

0.10

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

262

0.93

0.10

1.0

1.5

52.29

68.92

mg/l

0.93

171

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

212

1.08

0.10

1.1

1.4

18.00

22.53

0.36

178

(3035933) Granulocytes/100 leukocytes in Blood

1.08

0.09

2.0

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.08

0.09

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

777

0.97

0.09

1.2

1.3

0.97

0.80

nmol/l

0.65

619

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.06

0.09

7.6

4.7

20.00

55.16

ug/min

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.13

0.09

1.0

1.2

—

(3020650) Glucose [Presence] in Urine

0.88

0.09

3.1

1.4

—

(3048879) Bone marrow aspiration report

238

1.06

0.08

1.1

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

113

0.90

0.08

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

113

0.90

0.08

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

113

0.90

0.08

1.0

1.2

1.34

2.14

mmol/l

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

113

0.90

0.08

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

113

0.90

0.08

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

231

1.06

0.07

1.0

1.1

—

(3026782) Osmolality of Urine

1533

12879

1.01

0.07

3.3

3.2

545.69

530.06

mosm/kgh2o

2.37

1346

10995

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.07

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

116

1.09

0.07

1.1

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

129

0.92

0.07

1.1

—

(3024263) Appearance of Synovial fluid

315

1.05

0.06

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

438

0.96

0.06

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.10

0.06

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

254

2168

0.99

0.05

5.4

4.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

193

1650

0.99

0.05

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

193

1650

0.99

0.05

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

103

854

1.02

0.04

1.4

1.5

2.62

4.07

iu/l

2.37

228

(3026389) Candida sp identified in Specimen by Organism specific culture

678

1.02

0.04

1.4

—

(3003129) Base excess in Capillary blood by calculation

168

1.06

0.04

1.3

1.9

0.16

0.77

mmol/l

0.18

158

(3051593) INR in Capillary blood by Coagulation assay

444

1.03

0.04

8.8

14.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

154

1317

0.99

0.04

1.3

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.92

0.04

1.0

1.1

—

(3017704) Immunofixation for Urine

399

0.97

0.03

1.3

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

815

0.98

0.03

1.2

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

144

1.06

0.03

1.3

26.20

19.18

—

110

(3027801) Oxygen [Partial pressure] in Arterial blood

915

7701

1.00

0.03

3.7

5.8

11.16

11.58

kpa

1.76

863

7239

(3026692) Albumin [Mass/volume] in Peritoneal fluid

153

1.05

0.03

1.4

10.36

15.06

g/l

1.51

121

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

279

1.03

0.02

4.9

5.0

101.24

126.74

u/ml

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

915

7704

1.00

0.02

3.7

5.8

4.92

5.05

kpa

3.69

863

7242

(3003740) Influenza virus B Ag [Presence] in Specimen

159

0.96

0.02

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

116

0.95

0.02

1.3

1.1

242.29

269.30

pmol/l

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.07

0.01

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

226

0.97

0.01

6.2

6.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5326

44983

1.00

0.01

4.7

5.4

6.22

6.15

mmol/l

2.28

4239

39096

(3047181) Lactate [Moles/volume] in Blood

225

1908

1.00

0.01

4.0

5.3

1.39

1.36

mmol/l

0.15

205

1697

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

206

0.98

0.00

2.2

2.9

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

260

1.01

0.00

1.1

1.4

2.78

3.39

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

121

0.98

0.00

1.2

1.3

—

(40762814) Titanium [Mass/volume] in Blood

120

0.98

0.00

2.2

2.0

2.91

3.34

ug/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

158

1.02

0.00

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

119

1007

1.00

0.00

2.7

3.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

173

0.98

0.00

1.0

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.2

—

343.50

—

(4212803) Bone marrow aspirate examination

0.91

0.00

1.1

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

17.33

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.97

-0.00

1.1

1.6

43.44

49.44

umol/l

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

11.1

—

33.88

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.9

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.0

—

8.78

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

19.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.84

-0.00

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

37.67

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

64.94

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.90

-0.00

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

2.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.6

—

14.00

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.4

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

270.60

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_ALZHDEMENT and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_ALZHDEMENT	2.398 [2.17, 2.65]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.03

During the follow-up period (1.1.1998 — 31.12.2019), 48483 out of 70483 females with F5_ALZHDEMENT died.

Males

Parameter	HR [95% CI]	p-value
F5_ALZHDEMENT	2.838 [2.47, 3.27]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 27543 out of 38138 males with F5_ALZHDEMENT died.

Mortality risk

Mortality risk for people of age

years, who have F5_ALZHDEMENT.

N-year risk	Females	Males
1	0.185%	0.525%
5	1.168%	2.954%
10	3.006%	7.145%
15	5.373%	13.483%
20	9.032%	22.437%

Relationships between endpoints

↥

Index endpoint: F5_ALZHDEMENT – Dementia in Alzheimer disease

GWS hits: 17

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dementia in Alzheimer disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints